www.00gvb.com_www.00gvb.com-【APP官网】

社友网

2019-11-19 05:57:01

字体:标准

  Ourcompanyiscommittedtodiscoveringsmart,sustainablewaystoexpandaccesstohealthcare,especiallyinareaswithlimitedinfrastructureandresources.Giventhesignificanceofthischallenge,itisonlybyworkinginpartnershipwithothers—governments,donors,patientorganizations,healthcareprofessionals,NGOs,academicinstitutions,multilateralorganizationsandtheprivatesector—thatwecanwemakethestrongestcontribution.TheMSDFellowshipforGlobalHealthisbuiltonthenotionofpartneringtostrengthenthecapacityandreachofnonprofitorganizationswhich,inturn,willultimatelysolvesomeoftheworld’sgreatesthealthcarechallenges.Chemistryhasbeencentraltoourbusinessofsinceourearliestdaysasacompany.Historically,ourdrugdiscoveryprocessprimarilycenteredaroundsmallmolecules.Then,thebirthofbiotechnologyinthelate1970s/early1980saddedbiologics,orengineeredproteins,tothemix.Today,newmodalitiesareemergingthatshowastrongpotentialtotargetcomplexdiseasesthathavenotyetbeenreachablewitheithersmallmoleculesorbiologics.RobGarbaccioisleadingatalentedteamofchemistswhoarehelpingguideMSD’sentryintothisexcitingnewfieldofmedicine.IntroducinganddiscoveringnewwaysforwardRobistheassociatevicepresident,ChemistryCapabilitiesforAcceleratingTherapeutics(CCAT),adiscoverychemistryteamthatislookingathowtogobeyondthetraditionalmethodsofdiscoveringanddevelopingmedicines."Therearecertaindiseasetargetsthatarereallyhardto'reach'andimpactusingtraditionalmethods,"henotes."SopartofthegroupIoverseetriestofigureouthowwecanemploynewermodalities,suchaspeptides,bioconjugates,andoligonucleotides,toaddressthechallengingtargetsthatareincreasinglyemergingfrombiologicalresearch."Rob'sgroupisnotfocusedonanyspecifictherapeuticarea--theyareseekingnewwaystoaddressthemostdifficultdiseasetargets."Inoncology,infectiousdiseases,andneuroscience,forexample,we’relookingforthosetargetsthatourcolleaguessay,'Ifonlywecouldmodulatethistarget,webelievewemightbeabletopotentiallyinterruptthediseaseprocessandhelppatients,'"henotes.Using‘creativechemistry’totreatdiseaseIt'scomplexwork,tobesure,butthat'swhatmakesitsointriguingandinspiringforRobandhisteam."ThethingthatIlikethemostaboutmyworkisthebeliefthattheremaybeapathforwardforthetreatmentofeachandeveryoneofthesediseases.Wejustcan'tseeityetbecausethebiologyissocomplex,"saysRob."Asresearcherscontinuetoimproveourunderstandingofdiseasebiology,Ibelievethatcombiningthatknowledgewithcreativechemistrywillhelpleadusdownnewroadstotreatingdiseaseandhelpingpatients."Robjoinedthecompanyaftercompletinggraduateschoolandapostdoctoralfellowshipfocusingonorganicchemistry."Icameherebecausescienceandinnovationdrivethiscompany.I'mpassionateaboutourmissiontosaveandimprovelives,andIbelievethatmybestdayatwork,thedaymyteammakesapotentiallylife-changingdiscovery,isstillaheadofme,andit'sthereasonthatIstay."InventingforlifeAtMSD,wesayweare.AndRobdefinitelyseeshimselfasaninventor."Chemistshavethisuniqueabilitytocombineatomsandbondsbetweenatomsinauniqueway.Everydaychemistsareinventinghundredsofmoleculesthathaveneverexistedbefore.So,yes,weareinventing,"hesays."Weareinventingtosolveproblems."Toexpressourappreciation,MSDbegan#DearCancerHeroes–asocialmediacampaigntorecognizetheirfortitudeandcontributionstothefield.It’sasmallgesturetoshowourgratitude.Wewanttoletclinicaltrialparticipantsknowtheyarenotaloneandthereisawholecommunityofpeoplecheeringthemon.Anyonecanjointhemovementbywritingamessagetocancerclinicaltrialparticipantsonastickynoteandsharingitonsocialmediausing#DearCancerHeroes.Cancerresearchhascomealongwayandstillhasalongwaytogo.However,wewouldn’thavegottentowherewearetodaywithouttheseheroes.

  “MyuncleIvanwasaseverediabetespatient—heneededinjectionsthreetimesaday.Hewaswithoutinsulinformorethanamonth.EvenIwasnotaware,”Pablorecounts.“Whenhefinallyreceivedinsulin,hewasinbadcondition.Severalweekslater,hishealthdeclined,hehadrenalfailure,andhedied.”ThedroneteamrecentlyacknowledgedPablo’scontributions,andhispersonalloss,bygivingtheprojectanewnickname.Oncecalled“MajorTom”aftertheDavidBowiesong,it’snow“ProjectIvan.”“Idon’thavewordsenoughtoshowmygratitude,”Pablosays.“Thisisaboutsavinglives.”“MyuncleIvanwasaseverediabetespatient—heneededinjectionsthreetimesaday.Hewaswithoutinsulinformorethanamonth.EvenIwasnotaware,”Pablorecounts.“Whenhefinallyreceivedinsulin,hewasinbadcondition.Severalweekslater,hishealthdeclined,hehadrenalfailure,andhedied.”ThedroneteamrecentlyacknowledgedPablo’scontributions,andhispersonalloss,bygivingtheprojectanewnickname.Oncecalled“MajorTom”aftertheDavidBowiesong,it’snow“ProjectIvan.”“Idon’thavewordsenoughtoshowmygratitude,”Pablosays.“Thisisaboutsavinglives.”Jameslikeslogicpuzzles.Andwordproblems.Luckily,hegetstoapplytheseinterestsinhisworkeveryday.Jamesisacomputationalchemist–heworkswithMSD’schemistryteams,applyingpredictivemodellingtoidentifywaystodesigndrugsandanalyzedatatohelpourscientistsprioritizethenextcompoundstomakeandtest.Althoughthesearecomplexproblemsandcomplexquestionsthatwe’retryingtosolve,wetakelogicalsteps,explainsJames.Foreveryquestion,there’sreallyananswer,yousometimesjusthavetospendalittlebitmoretimethinkingaboutit,andtakeastepbackandlookatwhat’sactuallyinfrontofyou.Bettermolecules,fasterInourgroup’sroleindrugdiscovery,wehavethismantraof‘bettermolecules,faster,saysJames.Ifachemisthas100compoundsthatshe’sthinkingaboutmaking,computationally,wecanhelpprioritizewhichonestostartwithbasedonrationaldrugdesign.Jamesenjoysbeingpartofateamworkingtoachieveasingulargoal:tocreatemedicinesthatwillhelpthepeoplewhoneedthem.And,hebelievesthatcollaborationisveryimportantforresearchanddevelopment:Youcan'tdoaprojectonyourown;youneedotherstoassistandhelp,notjustbycontributingintheirindividualrole,butalsowiththeirthinking.Jamesandhiscolleagueshavealotofexperiencewithperseveranceanddetermination,too.Ourteamsofscientistsdesign,developandscreenthousandsofcompoundsandantibodiestoultimatelyadvanceonlyafewofthemostpromisingleadcandidatesintoclinicaltesting.Moleculardesignanddevelopmentisaniterativeprocess.Youhavetostickwithit.It'scontinuouslymakingmodificationsandadaptingandevolving,eventuallygettingdowntheroadorthepipelinetomakeadrug…that'swhat'sexcitingaboutit.It’sallaboutthepatientsEveryday,IcometoworkknowingthatI’mworkingtomakeadrug.And,Idon'tknowiftodayI’mgoingtoopenupanemailwithresultssaying,‘we'veaccomplishedthisor‘weneedtochangethat.’Butregardlessofwhatthoseresultsare,it'sgoingtobeprogresstogettothatendpoint.”

  Dr.Chenghasbeentreatingheadandneckcancerpatientsformanyyears.Thisishispersonalperspective.Ihavetreatedpatientswithheadandneckcancersformanyyears,soIhaveseen,upclose,thedifficultexperienceoflivingwithheadandneckcancer.Cancerisatryingsituationforallpatientsandtheirlovedones,butheadandneckpatientsfacecancerinauniqueanddifficultway,withtheirdiseaseandtumorsoftenvisibletothepublic.Ihavebeeninvolvedinresearchforyearsaspartofscientists'decades-longendeavortobringforwardmeaningfuladvancesforpatientsdiagnosedwiththispotentiallyaggressivedisease.Untilrecently,suchadvanceswerehardtocomebyandmypatientsandIstruggledwiththelimitedtreatmentoptionsavailable.Butwhilethereisasignificantneedfornewtreatmentoptions,thegoodnewsisthattherehavebeensomeimprovementsinsurvivalratesovertheyearsandweareseeinganewandencouragingfutureahead.Wehavebeguntoleverageourunderstandingofbiologytodevelopmoreprecisetherapies.AtMSD,wearefocusedonimmuno-oncologyresearch,whichstudiestheroleoftheimmunesystemindetectingandfightingcancer.Wearestudyingthepotentialofthisapproach,whichaimstoharnessandrestorethebodysabilitytodetectandfightcancercells,inanumberofcancers,includingheadandneckcancer.Immuno-oncologyhasalreadysignificantlychangedthewaycertaincancersaretreated,includingmelanomaandlungcancer,aswellasinthetreatmentofheadandneckcancer.Changeiscomingtotheheadandneckcancerlandscape–anditisthrillingtobeapartofit.TobeabletoseehowourresearchandeffortsatMSDarehavingadirectimpactonhowphysiciansapproachthetreatmentoftheirpatientsandwhatpatientsmayexpectfromtheirtreatmentiswhatmotivatesustoworkharder.“MyuncleIvanwasaseverediabetespatient—heneededinjectionsthreetimesaday.Hewaswithoutinsulinformorethanamonth.EvenIwasnotaware,”Pablorecounts.“Whenhefinallyreceivedinsulin,hewasinbadcondition.Severalweekslater,hishealthdeclined,hehadrenalfailure,andhedied.”ThedroneteamrecentlyacknowledgedPablo’scontributions,andhispersonalloss,bygivingtheprojectanewnickname.Oncecalled“MajorTom”aftertheDavidBowiesong,it’snow“ProjectIvan.”“Idon’thavewordsenoughtoshowmygratitude,”Pablosays.“Thisisaboutsavinglives.”Historically,oncologypracticeandclinicaltrialdesignprimarilyfocusedonwherethetumorfirstemerged,suchascolonorrectum,lung,breast,andendometrium.Thisapproachfollowsthelogicofthescalpel:pinpointingthelocationofthetumorfirstenabledsurgicalplans.Morerecently,therehavebeensignificantadvancesinourunderstandingoftheroleofcancerbiomarkersinmolecularandcellularmechanismsthatcandrivetumorgrowth.Biomarkersarebiologicalmolecules(typicallycomprisedofDNA,RNAorprotein)foundintissuesorbloodthatcanserveasasigntobetterunderstandaconditionordisease.Sometimes,thesamebiomarkerisfoundacrossmanydifferenttypesofcancer,regardlessofwherethetumorfirstdeveloped.Withinaspecifictumorlocation,thesebiomarkerscansometimesdifferentiatewhetherthetumorislikelytorespondtoagiventreatment.Assuch,thesebiomarkershavebeenusedtohelpinformclinicalresearch,acceleratingtheprocessofgettingtargetedmedicinestopatientswhereseparatetrialswouldtakeyearstoconduct.Importantly,insomecases,thesefeaturescanbeassessedusinglaboratoryteststhathavelongbeenavailable.Whereatestiseithernotavailable,orforresearchuseonly,thetestmanufacturerpartnerswiththedrugmanufacturertoadvancetogetherintoregulatoryapprovalbygovernmentagencies(suchastheFDA)acompaniondiagnosticassaytoensuresafeandeffectiveuseofthedruginpatientslikelytorespond.Thegoalistouseadeeperunderstandingofthetumorbiologyandassociatedbiomarkerstotackletumorresearchmoreprecisely;goingbeyondsimplywhereatumorarose.Instead,wearelearninghowtoattackacancerbasedonitsbiologyatthecellularlevel.AtMSD,effortsareunderwaytobetterunderstandmicrosatelliteinstability(MSI)andmismatchrepairdeficiency(dMMR).Thesebiomarkersarepresentacrosstumortypes,regardlessoftheoriginallocationofthecancer.ThepresenceofhighlevelsofMSI(MSI-H)ordMMRsignifiesanunderlyingprobleminacell'sabilitytofixerrorsthatoccurwhenDNAreplicates.TumorcellsdeterminedtohaveMSI-HordMMRharborhundredstothousandsofmutations.Theultimateproofofoureffortswillmanifestasanewgenerationofcancermedicines:thosethatfollowthelogicofbiology,notthelogicofthescalpel.

  “MyuncleIvanwasaseverediabetespatient—heneededinjectionsthreetimesaday.Hewaswithoutinsulinformorethanamonth.EvenIwasnotaware,”Pablorecounts.“Whenhefinallyreceivedinsulin,hewasinbadcondition.Severalweekslater,hishealthdeclined,hehadrenalfailure,andhedied.”ThedroneteamrecentlyacknowledgedPablo’scontributions,andhispersonalloss,bygivingtheprojectanewnickname.Oncecalled“MajorTom”aftertheDavidBowiesong,it’snow“ProjectIvan.”“Idon’thavewordsenoughtoshowmygratitude,”Pablosays.“Thisisaboutsavinglives.”Toexpressourappreciation,MSDbegan#DearCancerHeroes–asocialmediacampaigntorecognizetheirfortitudeandcontributionstothefield.It’sasmallgesturetoshowourgratitude.Wewanttoletclinicaltrialparticipantsknowtheyarenotaloneandthereisawholecommunityofpeoplecheeringthemon.Anyonecanjointhemovementbywritingamessagetocancerclinicaltrialparticipantsonastickynoteandsharingitonsocialmediausing#DearCancerHeroes.Cancerresearchhascomealongwayandstillhasalongwaytogo.However,wewouldn’thavegottentowherewearetodaywithouttheseheroes.Toexpressourappreciation,MSDbegan#DearCancerHeroes–asocialmediacampaigntorecognizetheirfortitudeandcontributionstothefield.It’sasmallgesturetoshowourgratitude.Wewanttoletclinicaltrialparticipantsknowtheyarenotaloneandthereisawholecommunityofpeoplecheeringthemon.Anyonecanjointhemovementbywritingamessagetocancerclinicaltrialparticipantsonastickynoteandsharingitonsocialmediausing#DearCancerHeroes.Cancerresearchhascomealongwayandstillhasalongwaytogo.However,wewouldn’thavegottentowherewearetodaywithouttheseheroes.

  Jameslikeslogicpuzzles.Andwordproblems.Luckily,hegetstoapplytheseinterestsinhisworkeveryday.Jamesisacomputationalchemist–heworkswithMSD’schemistryteams,applyingpredictivemodellingtoidentifywaystodesigndrugsandanalyzedatatohelpourscientistsprioritizethenextcompoundstomakeandtest.Althoughthesearecomplexproblemsandcomplexquestionsthatwe’retryingtosolve,wetakelogicalsteps,explainsJames.Foreveryquestion,there’sreallyananswer,yousometimesjusthavetospendalittlebitmoretimethinkingaboutit,andtakeastepbackandlookatwhat’sactuallyinfrontofyou.Bettermolecules,fasterInourgroup’sroleindrugdiscovery,wehavethismantraof‘bettermolecules,faster,saysJames.Ifachemisthas100compoundsthatshe’sthinkingaboutmaking,computationally,wecanhelpprioritizewhichonestostartwithbasedonrationaldrugdesign.Jamesenjoysbeingpartofateamworkingtoachieveasingulargoal:tocreatemedicinesthatwillhelpthepeoplewhoneedthem.And,hebelievesthatcollaborationisveryimportantforresearchanddevelopment:Youcan'tdoaprojectonyourown;youneedotherstoassistandhelp,notjustbycontributingintheirindividualrole,butalsowiththeirthinking.Jamesandhiscolleagueshavealotofexperiencewithperseveranceanddetermination,too.Ourteamsofscientistsdesign,developandscreenthousandsofcompoundsandantibodiestoultimatelyadvanceonlyafewofthemostpromisingleadcandidatesintoclinicaltesting.Moleculardesignanddevelopmentisaniterativeprocess.Youhavetostickwithit.It'scontinuouslymakingmodificationsandadaptingandevolving,eventuallygettingdowntheroadorthepipelinetomakeadrug…that'swhat'sexcitingaboutit.It’sallaboutthepatientsEveryday,IcometoworkknowingthatI’mworkingtomakeadrug.And,Idon'tknowiftodayI’mgoingtoopenupanemailwithresultssaying,‘we'veaccomplishedthisor‘weneedtochangethat.’Butregardlessofwhatthoseresultsare,it'sgoingtobeprogresstogettothatendpoint.”CarolineFox,M.D.ispassionateaboutgenetics.Inmedicalschool,shestudiedtheeffectsoftheenvironmentondiabetesandobesityonatribeofNativeAmericans(certainpopulationsworldwidehaveagreaterpropensitytowardsdiabetes;thistribewasonesuchgroup).Herresearchlefthermotivatedtolearnmoreabouthowgeneticsplaysaroleinmetabolicdiseases.Thatwasmystart,shenotes.Sincethen,almostallofmyresearchhasbeenfocusedonuncoveringthegeneticfoundationsofthesetypesofdiseases.ChangingPerceptionsPriortojoiningMSDResearchLaboratoriesinBoston,CarolineworkedattheNationalInstitutesofHealth.There,sheledalabthatstudiedmetabolicriskfactorsforcardiovasculardiseaseaspartofthe,apioneeringlong-termpopulationstudyofcardiovasculardisease.But,shenotes,theshifttoMSDwasarelativelyeasyone.IwasimpressedbyMSDseffortstoleveragehumangeneticstodrivedrugdiscovery,shesays.Forme,itwastheperfectnextstepfromtheworkthatIhadbeendoinginacademia.Genetics:TheNewFrontierWe'relucky—CarolinespassionforgeneticsisagreatfitforMSD.Inourlabsandacrosstheindustry,weareseeinganincreaseduseofhumangeneticstohelpdeterminewhetherpatientswillrespondtoacertaindrugornot,ShepointstoMSD'sactiveresearchcollaborationswithscientistsaroundtheworldaimedatadvancingthisfieldofscience.Iamveryenthusiasticaboutwhereourresearchmaylead.Historically,oncologypracticeandclinicaltrialdesignprimarilyfocusedonwherethetumorfirstemerged,suchascolonorrectum,lung,breast,andendometrium.Thisapproachfollowsthelogicofthescalpel:pinpointingthelocationofthetumorfirstenabledsurgicalplans.Morerecently,therehavebeensignificantadvancesinourunderstandingoftheroleofcancerbiomarkersinmolecularandcellularmechanismsthatcandrivetumorgrowth.Biomarkersarebiologicalmolecules(typicallycomprisedofDNA,RNAorprotein)foundintissuesorbloodthatcanserveasasigntobetterunderstandaconditionordisease.Sometimes,thesamebiomarkerisfoundacrossmanydifferenttypesofcancer,regardlessofwherethetumorfirstdeveloped.Withinaspecifictumorlocation,thesebiomarkerscansometimesdifferentiatewhetherthetumorislikelytorespondtoagiventreatment.Assuch,thesebiomarkershavebeenusedtohelpinformclinicalresearch,acceleratingtheprocessofgettingtargetedmedicinestopatientswhereseparatetrialswouldtakeyearstoconduct.Importantly,insomecases,thesefeaturescanbeassessedusinglaboratoryteststhathavelongbeenavailable.Whereatestiseithernotavailable,orforresearchuseonly,thetestmanufacturerpartnerswiththedrugmanufacturertoadvancetogetherintoregulatoryapprovalbygovernmentagencies(suchastheFDA)acompaniondiagnosticassaytoensuresafeandeffectiveuseofthedruginpatientslikelytorespond.Thegoalistouseadeeperunderstandingofthetumorbiologyandassociatedbiomarkerstotackletumorresearchmoreprecisely;goingbeyondsimplywhereatumorarose.Instead,wearelearninghowtoattackacancerbasedonitsbiologyatthecellularlevel.AtMSD,effortsareunderwaytobetterunderstandmicrosatelliteinstability(MSI)andmismatchrepairdeficiency(dMMR).Thesebiomarkersarepresentacrosstumortypes,regardlessoftheoriginallocationofthecancer.ThepresenceofhighlevelsofMSI(MSI-H)ordMMRsignifiesanunderlyingprobleminacell'sabilitytofixerrorsthatoccurwhenDNAreplicates.TumorcellsdeterminedtohaveMSI-HordMMRharborhundredstothousandsofmutations.Theultimateproofofoureffortswillmanifestasanewgenerationofcancermedicines:thosethatfollowthelogicofbiology,notthelogicofthescalpel.

  “MyuncleIvanwasaseverediabetespatient—heneededinjectionsthreetimesaday.Hewaswithoutinsulinformorethanamonth.EvenIwasnotaware,”Pablorecounts.“Whenhefinallyreceivedinsulin,hewasinbadcondition.Severalweekslater,hishealthdeclined,hehadrenalfailure,andhedied.”ThedroneteamrecentlyacknowledgedPablo’scontributions,andhispersonalloss,bygivingtheprojectanewnickname.Oncecalled“MajorTom”aftertheDavidBowiesong,it’snow“ProjectIvan.”“Idon’thavewordsenoughtoshowmygratitude,”Pablosays.“Thisisaboutsavinglives.”Historically,oncologypracticeandclinicaltrialdesignprimarilyfocusedonwherethetumorfirstemerged,suchascolonorrectum,lung,breast,andendometrium.Thisapproachfollowsthelogicofthescalpel:pinpointingthelocationofthetumorfirstenabledsurgicalplans.Morerecently,therehavebeensignificantadvancesinourunderstandingoftheroleofcancerbiomarkersinmolecularandcellularmechanismsthatcandrivetumorgrowth.Biomarkersarebiologicalmolecules(typicallycomprisedofDNA,RNAorprotein)foundintissuesorbloodthatcanserveasasigntobetterunderstandaconditionordisease.Sometimes,thesamebiomarkerisfoundacrossmanydifferenttypesofcancer,regardlessofwherethetumorfirstdeveloped.Withinaspecifictumorlocation,thesebiomarkerscansometimesdifferentiatewhetherthetumorislikelytorespondtoagiventreatment.Assuch,thesebiomarkershavebeenusedtohelpinformclinicalresearch,acceleratingtheprocessofgettingtargetedmedicinestopatientswhereseparatetrialswouldtakeyearstoconduct.Importantly,insomecases,thesefeaturescanbeassessedusinglaboratoryteststhathavelongbeenavailable.Whereatestiseithernotavailable,orforresearchuseonly,thetestmanufacturerpartnerswiththedrugmanufacturertoadvancetogetherintoregulatoryapprovalbygovernmentagencies(suchastheFDA)acompaniondiagnosticassaytoensuresafeandeffectiveuseofthedruginpatientslikelytorespond.Thegoalistouseadeeperunderstandingofthetumorbiologyandassociatedbiomarkerstotackletumorresearchmoreprecisely;goingbeyondsimplywhereatumorarose.Instead,wearelearninghowtoattackacancerbasedonitsbiologyatthecellularlevel.AtMSD,effortsareunderwaytobetterunderstandmicrosatelliteinstability(MSI)andmismatchrepairdeficiency(dMMR).Thesebiomarkersarepresentacrosstumortypes,regardlessoftheoriginallocationofthecancer.ThepresenceofhighlevelsofMSI(MSI-H)ordMMRsignifiesanunderlyingprobleminacell'sabilitytofixerrorsthatoccurwhenDNAreplicates.TumorcellsdeterminedtohaveMSI-HordMMRharborhundredstothousandsofmutations.Theultimateproofofoureffortswillmanifestasanewgenerationofcancermedicines:thosethatfollowthelogicofbiology,notthelogicofthescalpel.Dr.Chenghasbeentreatingheadandneckcancerpatientsformanyyears.Thisishispersonalperspective.Ihavetreatedpatientswithheadandneckcancersformanyyears,soIhaveseen,upclose,thedifficultexperienceoflivingwithheadandneckcancer.Cancerisatryingsituationforallpatientsandtheirlovedones,butheadandneckpatientsfacecancerinauniqueanddifficultway,withtheirdiseaseandtumorsoftenvisibletothepublic.Ihavebeeninvolvedinresearchforyearsaspartofscientists'decades-longendeavortobringforwardmeaningfuladvancesforpatientsdiagnosedwiththispotentiallyaggressivedisease.Untilrecently,suchadvanceswerehardtocomebyandmypatientsandIstruggledwiththelimitedtreatmentoptionsavailable.Butwhilethereisasignificantneedfornewtreatmentoptions,thegoodnewsisthattherehavebeensomeimprovementsinsurvivalratesovertheyearsandweareseeinganewandencouragingfutureahead.Wehavebeguntoleverageourunderstandingofbiologytodevelopmoreprecisetherapies.AtMSD,wearefocusedonimmuno-oncologyresearch,whichstudiestheroleoftheimmunesystemindetectingandfightingcancer.Wearestudyingthepotentialofthisapproach,whichaimstoharnessandrestorethebodysabilitytodetectandfightcancercells,inanumberofcancers,includingheadandneckcancer.Immuno-oncologyhasalreadysignificantlychangedthewaycertaincancersaretreated,includingmelanomaandlungcancer,aswellasinthetreatmentofheadandneckcancer.Changeiscomingtotheheadandneckcancerlandscape–anditisthrillingtobeapartofit.TobeabletoseehowourresearchandeffortsatMSDarehavingadirectimpactonhowphysiciansapproachthetreatmentoftheirpatientsandwhatpatientsmayexpectfromtheirtreatmentiswhatmotivatesustoworkharder.

  Jameslikeslogicpuzzles.Andwordproblems.Luckily,hegetstoapplytheseinterestsinhisworkeveryday.Jamesisacomputationalchemist–heworkswithMSD’schemistryteams,applyingpredictivemodellingtoidentifywaystodesigndrugsandanalyzedatatohelpourscientistsprioritizethenextcompoundstomakeandtest.Althoughthesearecomplexproblemsandcomplexquestionsthatwe’retryingtosolve,wetakelogicalsteps,explainsJames.Foreveryquestion,there’sreallyananswer,yousometimesjusthavetospendalittlebitmoretimethinkingaboutit,andtakeastepbackandlookatwhat’sactuallyinfrontofyou.Bettermolecules,fasterInourgroup’sroleindrugdiscovery,wehavethismantraof‘bettermolecules,faster,saysJames.Ifachemisthas100compoundsthatshe’sthinkingaboutmaking,computationally,wecanhelpprioritizewhichonestostartwithbasedonrationaldrugdesign.Jamesenjoysbeingpartofateamworkingtoachieveasingulargoal:tocreatemedicinesthatwillhelpthepeoplewhoneedthem.And,hebelievesthatcollaborationisveryimportantforresearchanddevelopment:Youcan'tdoaprojectonyourown;youneedotherstoassistandhelp,notjustbycontributingintheirindividualrole,butalsowiththeirthinking.Jamesandhiscolleagueshavealotofexperiencewithperseveranceanddetermination,too.Ourteamsofscientistsdesign,developandscreenthousandsofcompoundsandantibodiestoultimatelyadvanceonlyafewofthemostpromisingleadcandidatesintoclinicaltesting.Moleculardesignanddevelopmentisaniterativeprocess.Youhavetostickwithit.It'scontinuouslymakingmodificationsandadaptingandevolving,eventuallygettingdowntheroadorthepipelinetomakeadrug…that'swhat'sexcitingaboutit.It’sallaboutthepatientsEveryday,IcometoworkknowingthatI’mworkingtomakeadrug.And,Idon'tknowiftodayI’mgoingtoopenupanemailwithresultssaying,‘we'veaccomplishedthisor‘weneedtochangethat.’Butregardlessofwhatthoseresultsare,it'sgoingtobeprogresstogettothatendpoint.”Chemistryhasbeencentraltoourbusinessofsinceourearliestdaysasacompany.Historically,ourdrugdiscoveryprocessprimarilycenteredaroundsmallmolecules.Then,thebirthofbiotechnologyinthelate1970s/early1980saddedbiologics,orengineeredproteins,tothemix.Today,newmodalitiesareemergingthatshowastrongpotentialtotargetcomplexdiseasesthathavenotyetbeenreachablewitheithersmallmoleculesorbiologics.RobGarbaccioisleadingatalentedteamofchemistswhoarehelpingguideMSD’sentryintothisexcitingnewfieldofmedicine.IntroducinganddiscoveringnewwaysforwardRobistheassociatevicepresident,ChemistryCapabilitiesforAcceleratingTherapeutics(CCAT),adiscoverychemistryteamthatislookingathowtogobeyondthetraditionalmethodsofdiscoveringanddevelopingmedicines."Therearecertaindiseasetargetsthatarereallyhardto'reach'andimpactusingtraditionalmethods,"henotes."SopartofthegroupIoverseetriestofigureouthowwecanemploynewermodalities,suchaspeptides,bioconjugates,andoligonucleotides,toaddressthechallengingtargetsthatareincreasinglyemergingfrombiologicalresearch."Rob'sgroupisnotfocusedonanyspecifictherapeuticarea--theyareseekingnewwaystoaddressthemostdifficultdiseasetargets."Inoncology,infectiousdiseases,andneuroscience,forexample,we’relookingforthosetargetsthatourcolleaguessay,'Ifonlywecouldmodulatethistarget,webelievewemightbeabletopotentiallyinterruptthediseaseprocessandhelppatients,'"henotes.Using‘creativechemistry’totreatdiseaseIt'scomplexwork,tobesure,butthat'swhatmakesitsointriguingandinspiringforRobandhisteam."ThethingthatIlikethemostaboutmyworkisthebeliefthattheremaybeapathforwardforthetreatmentofeachandeveryoneofthesediseases.Wejustcan'tseeityetbecausethebiologyissocomplex,"saysRob."Asresearcherscontinuetoimproveourunderstandingofdiseasebiology,Ibelievethatcombiningthatknowledgewithcreativechemistrywillhelpleadusdownnewroadstotreatingdiseaseandhelpingpatients."Robjoinedthecompanyaftercompletinggraduateschoolandapostdoctoralfellowshipfocusingonorganicchemistry."Icameherebecausescienceandinnovationdrivethiscompany.I'mpassionateaboutourmissiontosaveandimprovelives,andIbelievethatmybestdayatwork,thedaymyteammakesapotentiallylife-changingdiscovery,isstillaheadofme,andit'sthereasonthatIstay."InventingforlifeAtMSD,wesayweare.AndRobdefinitelyseeshimselfasaninventor."Chemistshavethisuniqueabilitytocombineatomsandbondsbetweenatomsinauniqueway.Everydaychemistsareinventinghundredsofmoleculesthathaveneverexistedbefore.So,yes,weareinventing,"hesays."Weareinventingtosolveproblems."Ourcompanyiscommittedtodiscoveringsmart,sustainablewaystoexpandaccesstohealthcare,especiallyinareaswithlimitedinfrastructureandresources.Giventhesignificanceofthischallenge,itisonlybyworkinginpartnershipwithothers—governments,donors,patientorganizations,healthcareprofessionals,NGOs,academicinstitutions,multilateralorganizationsandtheprivatesector—thatwecanwemakethestrongestcontribution.TheMSDFellowshipforGlobalHealthisbuiltonthenotionofpartneringtostrengthenthecapacityandreachofnonprofitorganizationswhich,inturn,willultimatelysolvesomeoftheworld’sgreatesthealthcarechallenges.

  In1962hercollaborators,JamesWatson,FrancisCrickandMauriceWilkinswereawardedtheNobelPrizefortheir“discoveriesconcerningthemolecularstructureofnucleicacidsanditssignificanceforinformationtransferinlivingmaterial.”Franklin’suntimelydeathdeniedhertheacclaimofthisprestigiousscientificaward(theNobelCommitteedoesnotawardtheprizeposthumously),butherroleinthisfundamentaldiscoveryhasbeenwelldocumentedandisnowwidelyrecognized.Franklin’sstoryofalifecutshortbyovariancancerremainsalltoocommon.Eventoday,advancedovariancancerremainsoneofthemostdifficultcancerstotreat.Butthereremainsareasonforoptimism.Thepaceofchangeincancertreatmenthasincreaseddramaticallyinrecentyears.Advancesinresearch–manyofwhichmaybetracedbacktoFranklin’swork–havegivenusadeeperunderstandingofhowtotargetthedisease,pavingthewayfornewdevelopments.Specifictoovariancancer,recentclinicalresearchhasshownpromiseforwomenwithadvancedstagesofthedisease.AtMSD,wearefocusedontranslatingbreakthroughscienceintooncologytherapeuticsthathavethegreatestpotentialforimprovinglong-termdiseasecontrolandsurvivalforpatients,includingthosewithovariancancer.Werecognizethatnotwopatientsorcancersarethesameandmultipleapproaches–therapeuticregimensandmechanismsofaction–willbeneededtooutpacethisdisease.That’swhywehaveworkedrigorouslytoexpandanddiversifyourowninternalresearchprograms.Thereisstillworktobedone,butwebelievestronglyinourpotentialtotransformthewayallcancersaretreated.AndweareconstantlyinspiredtoworkharderbystorieslikeRosalindFranklin’s.Ourcompanyiscommittedtodiscoveringsmart,sustainablewaystoexpandaccesstohealthcare,especiallyinareaswithlimitedinfrastructureandresources.Giventhesignificanceofthischallenge,itisonlybyworkinginpartnershipwithothers—governments,donors,patientorganizations,healthcareprofessionals,NGOs,academicinstitutions,multilateralorganizationsandtheprivatesector—thatwecanwemakethestrongestcontribution.TheMSDFellowshipforGlobalHealthisbuiltonthenotionofpartneringtostrengthenthecapacityandreachofnonprofitorganizationswhich,inturn,willultimatelysolvesomeoftheworld’sgreatesthealthcarechallenges.Toexpressourappreciation,MSDbegan#DearCancerHeroes–asocialmediacampaigntorecognizetheirfortitudeandcontributionstothefield.It’sasmallgesturetoshowourgratitude.Wewanttoletclinicaltrialparticipantsknowtheyarenotaloneandthereisawholecommunityofpeoplecheeringthemon.Anyonecanjointhemovementbywritingamessagetocancerclinicaltrialparticipantsonastickynoteandsharingitonsocialmediausing#DearCancerHeroes.Cancerresearchhascomealongwayandstillhasalongwaytogo.However,wewouldn’thavegottentowherewearetodaywithouttheseheroes.

  Ourcompanyiscommittedtodiscoveringsmart,sustainablewaystoexpandaccesstohealthcare,especiallyinareaswithlimitedinfrastructureandresources.Giventhesignificanceofthischallenge,itisonlybyworkinginpartnershipwithothers—governments,donors,patientorganizations,healthcareprofessionals,NGOs,academicinstitutions,multilateralorganizationsandtheprivatesector—thatwecanwemakethestrongestcontribution.TheMSDFellowshipforGlobalHealthisbuiltonthenotionofpartneringtostrengthenthecapacityandreachofnonprofitorganizationswhich,inturn,willultimatelysolvesomeoftheworld’sgreatesthealthcarechallenges.Jameslikeslogicpuzzles.Andwordproblems.Luckily,hegetstoapplytheseinterestsinhisworkeveryday.Jamesisacomputationalchemist–heworkswithMSD’schemistryteams,applyingpredictivemodellingtoidentifywaystodesigndrugsandanalyzedatatohelpourscientistsprioritizethenextcompoundstomakeandtest.Althoughthesearecomplexproblemsandcomplexquestionsthatwe’retryingtosolve,wetakelogicalsteps,explainsJames.Foreveryquestion,there’sreallyananswer,yousometimesjusthavetospendalittlebitmoretimethinkingaboutit,andtakeastepbackandlookatwhat’sactuallyinfrontofyou.Bettermolecules,fasterInourgroup’sroleindrugdiscovery,wehavethismantraof‘bettermolecules,faster,saysJames.Ifachemisthas100compoundsthatshe’sthinkingaboutmaking,computationally,wecanhelpprioritizewhichonestostartwithbasedonrationaldrugdesign.Jamesenjoysbeingpartofateamworkingtoachieveasingulargoal:tocreatemedicinesthatwillhelpthepeoplewhoneedthem.And,hebelievesthatcollaborationisveryimportantforresearchanddevelopment:Youcan'tdoaprojectonyourown;youneedotherstoassistandhelp,notjustbycontributingintheirindividualrole,butalsowiththeirthinking.Jamesandhiscolleagueshavealotofexperiencewithperseveranceanddetermination,too.Ourteamsofscientistsdesign,developandscreenthousandsofcompoundsandantibodiestoultimatelyadvanceonlyafewofthemostpromisingleadcandidatesintoclinicaltesting.Moleculardesignanddevelopmentisaniterativeprocess.Youhavetostickwithit.It'scontinuouslymakingmodificationsandadaptingandevolving,eventuallygettingdowntheroadorthepipelinetomakeadrug…that'swhat'sexcitingaboutit.It’sallaboutthepatientsEveryday,IcometoworkknowingthatI’mworkingtomakeadrug.And,Idon'tknowiftodayI’mgoingtoopenupanemailwithresultssaying,‘we'veaccomplishedthisor‘weneedtochangethat.’Butregardlessofwhatthoseresultsare,it'sgoingtobeprogresstogettothatendpoint.”Ourcompanyiscommittedtodiscoveringsmart,sustainablewaystoexpandaccesstohealthcare,especiallyinareaswithlimitedinfrastructureandresources.Giventhesignificanceofthischallenge,itisonlybyworkinginpartnershipwithothers—governments,donors,patientorganizations,healthcareprofessionals,NGOs,academicinstitutions,multilateralorganizationsandtheprivatesector—thatwecanwemakethestrongestcontribution.TheMSDFellowshipforGlobalHealthisbuiltonthenotionofpartneringtostrengthenthecapacityandreachofnonprofitorganizationswhich,inturn,willultimatelysolvesomeoftheworld’sgreatesthealthcarechallenges.

  Ourcompanyiscommittedtodiscoveringsmart,sustainablewaystoexpandaccesstohealthcare,especiallyinareaswithlimitedinfrastructureandresources.Giventhesignificanceofthischallenge,itisonlybyworkinginpartnershipwithothers—governments,donors,patientorganizations,healthcareprofessionals,NGOs,academicinstitutions,multilateralorganizationsandtheprivatesector—thatwecanwemakethestrongestcontribution.TheMSDFellowshipforGlobalHealthisbuiltonthenotionofpartneringtostrengthenthecapacityandreachofnonprofitorganizationswhich,inturn,willultimatelysolvesomeoftheworld’sgreatesthealthcarechallenges.Ourcompanyiscommittedtodiscoveringsmart,sustainablewaystoexpandaccesstohealthcare,especiallyinareaswithlimitedinfrastructureandresources.Giventhesignificanceofthischallenge,itisonlybyworkinginpartnershipwithothers—governments,donors,patientorganizations,healthcareprofessionals,NGOs,academicinstitutions,multilateralorganizationsandtheprivatesector—thatwecanwemakethestrongestcontribution.TheMSDFellowshipforGlobalHealthisbuiltonthenotionofpartneringtostrengthenthecapacityandreachofnonprofitorganizationswhich,inturn,willultimatelysolvesomeoftheworld’sgreatesthealthcarechallenges.Ourcompanyiscommittedtodiscoveringsmart,sustainablewaystoexpandaccesstohealthcare,especiallyinareaswithlimitedinfrastructureandresources.Giventhesignificanceofthischallenge,itisonlybyworkinginpartnershipwithothers—governments,donors,patientorganizations,healthcareprofessionals,NGOs,academicinstitutions,multilateralorganizationsandtheprivatesector—thatwecanwemakethestrongestcontribution.TheMSDFellowshipforGlobalHealthisbuiltonthenotionofpartneringtostrengthenthecapacityandreachofnonprofitorganizationswhich,inturn,willultimatelysolvesomeoftheworld’sgreatesthealthcarechallenges.

  Toexpressourappreciation,MSDbegan#DearCancerHeroes–asocialmediacampaigntorecognizetheirfortitudeandcontributionstothefield.It’sasmallgesturetoshowourgratitude.Wewanttoletclinicaltrialparticipantsknowtheyarenotaloneandthereisawholecommunityofpeoplecheeringthemon.Anyonecanjointhemovementbywritingamessagetocancerclinicaltrialparticipantsonastickynoteandsharingitonsocialmediausing#DearCancerHeroes.Cancerresearchhascomealongwayandstillhasalongwaytogo.However,wewouldn’thavegottentowherewearetodaywithouttheseheroes.Toexpressourappreciation,MSDbegan#DearCancerHeroes–asocialmediacampaigntorecognizetheirfortitudeandcontributionstothefield.It’sasmallgesturetoshowourgratitude.Wewanttoletclinicaltrialparticipantsknowtheyarenotaloneandthereisawholecommunityofpeoplecheeringthemon.Anyonecanjointhemovementbywritingamessagetocancerclinicaltrialparticipantsonastickynoteandsharingitonsocialmediausing#DearCancerHeroes.Cancerresearchhascomealongwayandstillhasalongwaytogo.However,wewouldn’thavegottentowherewearetodaywithouttheseheroes.CarolineFox,M.D.ispassionateaboutgenetics.Inmedicalschool,shestudiedtheeffectsoftheenvironmentondiabetesandobesityonatribeofNativeAmericans(certainpopulationsworldwidehaveagreaterpropensitytowardsdiabetes;thistribewasonesuchgroup).Herresearchlefthermotivatedtolearnmoreabouthowgeneticsplaysaroleinmetabolicdiseases.Thatwasmystart,shenotes.Sincethen,almostallofmyresearchhasbeenfocusedonuncoveringthegeneticfoundationsofthesetypesofdiseases.ChangingPerceptionsPriortojoiningMSDResearchLaboratoriesinBoston,CarolineworkedattheNationalInstitutesofHealth.There,sheledalabthatstudiedmetabolicriskfactorsforcardiovasculardiseaseaspartofthe,apioneeringlong-termpopulationstudyofcardiovasculardisease.But,shenotes,theshifttoMSDwasarelativelyeasyone.IwasimpressedbyMSDseffortstoleveragehumangeneticstodrivedrugdiscovery,shesays.Forme,itwastheperfectnextstepfromtheworkthatIhadbeendoinginacademia.Genetics:TheNewFrontierWe'relucky—CarolinespassionforgeneticsisagreatfitforMSD.Inourlabsandacrosstheindustry,weareseeinganincreaseduseofhumangeneticstohelpdeterminewhetherpatientswillrespondtoacertaindrugornot,ShepointstoMSD'sactiveresearchcollaborationswithscientistsaroundtheworldaimedatadvancingthisfieldofscience.Iamveryenthusiasticaboutwhereourresearchmaylead.

  “MyuncleIvanwasaseverediabetespatient—heneededinjectionsthreetimesaday.Hewaswithoutinsulinformorethanamonth.EvenIwasnotaware,”Pablorecounts.“Whenhefinallyreceivedinsulin,hewasinbadcondition.Severalweekslater,hishealthdeclined,hehadrenalfailure,andhedied.”ThedroneteamrecentlyacknowledgedPablo’scontributions,andhispersonalloss,bygivingtheprojectanewnickname.Oncecalled“MajorTom”aftertheDavidBowiesong,it’snow“ProjectIvan.”“Idon’thavewordsenoughtoshowmygratitude,”Pablosays.“Thisisaboutsavinglives.”“MyuncleIvanwasaseverediabetespatient—heneededinjectionsthreetimesaday.Hewaswithoutinsulinformorethanamonth.EvenIwasnotaware,”Pablorecounts.“Whenhefinallyreceivedinsulin,hewasinbadcondition.Severalweekslater,hishealthdeclined,hehadrenalfailure,andhedied.”ThedroneteamrecentlyacknowledgedPablo’scontributions,andhispersonalloss,bygivingtheprojectanewnickname.Oncecalled“MajorTom”aftertheDavidBowiesong,it’snow“ProjectIvan.”“Idon’thavewordsenoughtoshowmygratitude,”Pablosays.“Thisisaboutsavinglives.”Dr.Chenghasbeentreatingheadandneckcancerpatientsformanyyears.Thisishispersonalperspective.Ihavetreatedpatientswithheadandneckcancersformanyyears,soIhaveseen,upclose,thedifficultexperienceoflivingwithheadandneckcancer.Cancerisatryingsituationforallpatientsandtheirlovedones,butheadandneckpatientsfacecancerinauniqueanddifficultway,withtheirdiseaseandtumorsoftenvisibletothepublic.Ihavebeeninvolvedinresearchforyearsaspartofscientists'decades-longendeavortobringforwardmeaningfuladvancesforpatientsdiagnosedwiththispotentiallyaggressivedisease.Untilrecently,suchadvanceswerehardtocomebyandmypatientsandIstruggledwiththelimitedtreatmentoptionsavailable.Butwhilethereisasignificantneedfornewtreatmentoptions,thegoodnewsisthattherehavebeensomeimprovementsinsurvivalratesovertheyearsandweareseeinganewandencouragingfutureahead.Wehavebeguntoleverageourunderstandingofbiologytodevelopmoreprecisetherapies.AtMSD,wearefocusedonimmuno-oncologyresearch,whichstudiestheroleoftheimmunesystemindetectingandfightingcancer.Wearestudyingthepotentialofthisapproach,whichaimstoharnessandrestorethebodysabilitytodetectandfightcancercells,inanumberofcancers,includingheadandneckcancer.Immuno-oncologyhasalreadysignificantlychangedthewaycertaincancersaretreated,includingmelanomaandlungcancer,aswellasinthetreatmentofheadandneckcancer.Changeiscomingtotheheadandneckcancerlandscape–anditisthrillingtobeapartofit.TobeabletoseehowourresearchandeffortsatMSDarehavingadirectimpactonhowphysiciansapproachthetreatmentoftheirpatientsandwhatpatientsmayexpectfromtheirtreatmentiswhatmotivatesustoworkharder.

  Chemistryhasbeencentraltoourbusinessofsinceourearliestdaysasacompany.Historically,ourdrugdiscoveryprocessprimarilycenteredaroundsmallmolecules.Then,thebirthofbiotechnologyinthelate1970s/early1980saddedbiologics,orengineeredproteins,tothemix.Today,newmodalitiesareemergingthatshowastrongpotentialtotargetcomplexdiseasesthathavenotyetbeenreachablewitheithersmallmoleculesorbiologics.RobGarbaccioisleadingatalentedteamofchemistswhoarehelpingguideMSD’sentryintothisexcitingnewfieldofmedicine.IntroducinganddiscoveringnewwaysforwardRobistheassociatevicepresident,ChemistryCapabilitiesforAcceleratingTherapeutics(CCAT),adiscoverychemistryteamthatislookingathowtogobeyondthetraditionalmethodsofdiscoveringanddevelopingmedicines."Therearecertaindiseasetargetsthatarereallyhardto'reach'andimpactusingtraditionalmethods,"henotes."SopartofthegroupIoverseetriestofigureouthowwecanemploynewermodalities,suchaspeptides,bioconjugates,andoligonucleotides,toaddressthechallengingtargetsthatareincreasinglyemergingfrombiologicalresearch."Rob'sgroupisnotfocusedonanyspecifictherapeuticarea--theyareseekingnewwaystoaddressthemostdifficultdiseasetargets."Inoncology,infectiousdiseases,andneuroscience,forexample,we’relookingforthosetargetsthatourcolleaguessay,'Ifonlywecouldmodulatethistarget,webelievewemightbeabletopotentiallyinterruptthediseaseprocessandhelppatients,'"henotes.Using‘creativechemistry’totreatdiseaseIt'scomplexwork,tobesure,butthat'swhatmakesitsointriguingandinspiringforRobandhisteam."ThethingthatIlikethemostaboutmyworkisthebeliefthattheremaybeapathforwardforthetreatmentofeachandeveryoneofthesediseases.Wejustcan'tseeityetbecausethebiologyissocomplex,"saysRob."Asresearcherscontinuetoimproveourunderstandingofdiseasebiology,Ibelievethatcombiningthatknowledgewithcreativechemistrywillhelpleadusdownnewroadstotreatingdiseaseandhelpingpatients."Robjoinedthecompanyaftercompletinggraduateschoolandapostdoctoralfellowshipfocusingonorganicchemistry."Icameherebecausescienceandinnovationdrivethiscompany.I'mpassionateaboutourmissiontosaveandimprovelives,andIbelievethatmybestdayatwork,thedaymyteammakesapotentiallylife-changingdiscovery,isstillaheadofme,andit'sthereasonthatIstay."InventingforlifeAtMSD,wesayweare.AndRobdefinitelyseeshimselfasaninventor."Chemistshavethisuniqueabilitytocombineatomsandbondsbetweenatomsinauniqueway.Everydaychemistsareinventinghundredsofmoleculesthathaveneverexistedbefore.So,yes,weareinventing,"hesays."Weareinventingtosolveproblems."“MyuncleIvanwasaseverediabetespatient—heneededinjectionsthreetimesaday.Hewaswithoutinsulinformorethanamonth.EvenIwasnotaware,”Pablorecounts.“Whenhefinallyreceivedinsulin,hewasinbadcondition.Severalweekslater,hishealthdeclined,hehadrenalfailure,andhedied.”ThedroneteamrecentlyacknowledgedPablo’scontributions,andhispersonalloss,bygivingtheprojectanewnickname.Oncecalled“MajorTom”aftertheDavidBowiesong,it’snow“ProjectIvan.”“Idon’thavewordsenoughtoshowmygratitude,”Pablosays.“Thisisaboutsavinglives.”In1962hercollaborators,JamesWatson,FrancisCrickandMauriceWilkinswereawardedtheNobelPrizefortheir“discoveriesconcerningthemolecularstructureofnucleicacidsanditssignificanceforinformationtransferinlivingmaterial.”Franklin’suntimelydeathdeniedhertheacclaimofthisprestigiousscientificaward(theNobelCommitteedoesnotawardtheprizeposthumously),butherroleinthisfundamentaldiscoveryhasbeenwelldocumentedandisnowwidelyrecognized.Franklin’sstoryofalifecutshortbyovariancancerremainsalltoocommon.Eventoday,advancedovariancancerremainsoneofthemostdifficultcancerstotreat.Butthereremainsareasonforoptimism.Thepaceofchangeincancertreatmenthasincreaseddramaticallyinrecentyears.Advancesinresearch–manyofwhichmaybetracedbacktoFranklin’swork–havegivenusadeeperunderstandingofhowtotargetthedisease,pavingthewayfornewdevelopments.Specifictoovariancancer,recentclinicalresearchhasshownpromiseforwomenwithadvancedstagesofthedisease.AtMSD,wearefocusedontranslatingbreakthroughscienceintooncologytherapeuticsthathavethegreatestpotentialforimprovinglong-termdiseasecontrolandsurvivalforpatients,includingthosewithovariancancer.Werecognizethatnotwopatientsorcancersarethesameandmultipleapproaches–therapeuticregimensandmechanismsofaction–willbeneededtooutpacethisdisease.That’swhywehaveworkedrigorouslytoexpandanddiversifyourowninternalresearchprograms.Thereisstillworktobedone,butwebelievestronglyinourpotentialtotransformthewayallcancersaretreated.AndweareconstantlyinspiredtoworkharderbystorieslikeRosalindFranklin’s.

  Toexpressourappreciation,MSDbegan#DearCancerHeroes–asocialmediacampaigntorecognizetheirfortitudeandcontributionstothefield.It’sasmallgesturetoshowourgratitude.Wewanttoletclinicaltrialparticipantsknowtheyarenotaloneandthereisawholecommunityofpeoplecheeringthemon.Anyonecanjointhemovementbywritingamessagetocancerclinicaltrialparticipantsonastickynoteandsharingitonsocialmediausing#DearCancerHeroes.Cancerresearchhascomealongwayandstillhasalongwaytogo.However,wewouldn’thavegottentowherewearetodaywithouttheseheroes.Ourcompanyiscommittedtodiscoveringsmart,sustainablewaystoexpandaccesstohealthcare,especiallyinareaswithlimitedinfrastructureandresources.Giventhesignificanceofthischallenge,itisonlybyworkinginpartnershipwithothers—governments,donors,patientorganizations,healthcareprofessionals,NGOs,academicinstitutions,multilateralorganizationsandtheprivatesector—thatwecanwemakethestrongestcontribution.TheMSDFellowshipforGlobalHealthisbuiltonthenotionofpartneringtostrengthenthecapacityandreachofnonprofitorganizationswhich,inturn,willultimatelysolvesomeoftheworld’sgreatesthealthcarechallenges.Historically,oncologypracticeandclinicaltrialdesignprimarilyfocusedonwherethetumorfirstemerged,suchascolonorrectum,lung,breast,andendometrium.Thisapproachfollowsthelogicofthescalpel:pinpointingthelocationofthetumorfirstenabledsurgicalplans.Morerecently,therehavebeensignificantadvancesinourunderstandingoftheroleofcancerbiomarkersinmolecularandcellularmechanismsthatcandrivetumorgrowth.Biomarkersarebiologicalmolecules(typicallycomprisedofDNA,RNAorprotein)foundintissuesorbloodthatcanserveasasigntobetterunderstandaconditionordisease.Sometimes,thesamebiomarkerisfoundacrossmanydifferenttypesofcancer,regardlessofwherethetumorfirstdeveloped.Withinaspecifictumorlocation,thesebiomarkerscansometimesdifferentiatewhetherthetumorislikelytorespondtoagiventreatment.Assuch,thesebiomarkershavebeenusedtohelpinformclinicalresearch,acceleratingtheprocessofgettingtargetedmedicinestopatientswhereseparatetrialswouldtakeyearstoconduct.Importantly,insomecases,thesefeaturescanbeassessedusinglaboratoryteststhathavelongbeenavailable.Whereatestiseithernotavailable,orforresearchuseonly,thetestmanufacturerpartnerswiththedrugmanufacturertoadvancetogetherintoregulatoryapprovalbygovernmentagencies(suchastheFDA)acompaniondiagnosticassaytoensuresafeandeffectiveuseofthedruginpatientslikelytorespond.Thegoalistouseadeeperunderstandingofthetumorbiologyandassociatedbiomarkerstotackletumorresearchmoreprecisely;goingbeyondsimplywhereatumorarose.Instead,wearelearninghowtoattackacancerbasedonitsbiologyatthecellularlevel.AtMSD,effortsareunderwaytobetterunderstandmicrosatelliteinstability(MSI)andmismatchrepairdeficiency(dMMR).Thesebiomarkersarepresentacrosstumortypes,regardlessoftheoriginallocationofthecancer.ThepresenceofhighlevelsofMSI(MSI-H)ordMMRsignifiesanunderlyingprobleminacell'sabilitytofixerrorsthatoccurwhenDNAreplicates.TumorcellsdeterminedtohaveMSI-HordMMRharborhundredstothousandsofmutations.Theultimateproofofoureffortswillmanifestasanewgenerationofcancermedicines:thosethatfollowthelogicofbiology,notthelogicofthescalpel.

  Jameslikeslogicpuzzles.Andwordproblems.Luckily,hegetstoapplytheseinterestsinhisworkeveryday.Jamesisacomputationalchemist–heworkswithMSD’schemistryteams,applyingpredictivemodellingtoidentifywaystodesigndrugsandanalyzedatatohelpourscientistsprioritizethenextcompoundstomakeandtest.Althoughthesearecomplexproblemsandcomplexquestionsthatwe’retryingtosolve,wetakelogicalsteps,explainsJames.Foreveryquestion,there’sreallyananswer,yousometimesjusthavetospendalittlebitmoretimethinkingaboutit,andtakeastepbackandlookatwhat’sactuallyinfrontofyou.Bettermolecules,fasterInourgroup’sroleindrugdiscovery,wehavethismantraof‘bettermolecules,faster,saysJames.Ifachemisthas100compoundsthatshe’sthinkingaboutmaking,computationally,wecanhelpprioritizewhichonestostartwithbasedonrationaldrugdesign.Jamesenjoysbeingpartofateamworkingtoachieveasingulargoal:tocreatemedicinesthatwillhelpthepeoplewhoneedthem.And,hebelievesthatcollaborationisveryimportantforresearchanddevelopment:Youcan'tdoaprojectonyourown;youneedotherstoassistandhelp,notjustbycontributingintheirindividualrole,butalsowiththeirthinking.Jamesandhiscolleagueshavealotofexperiencewithperseveranceanddetermination,too.Ourteamsofscientistsdesign,developandscreenthousandsofcompoundsandantibodiestoultimatelyadvanceonlyafewofthemostpromisingleadcandidatesintoclinicaltesting.Moleculardesignanddevelopmentisaniterativeprocess.Youhavetostickwithit.It'scontinuouslymakingmodificationsandadaptingandevolving,eventuallygettingdowntheroadorthepipelinetomakeadrug…that'swhat'sexcitingaboutit.It’sallaboutthepatientsEveryday,IcometoworkknowingthatI’mworkingtomakeadrug.And,Idon'tknowiftodayI’mgoingtoopenupanemailwithresultssaying,‘we'veaccomplishedthisor‘weneedtochangethat.’Butregardlessofwhatthoseresultsare,it'sgoingtobeprogresstogettothatendpoint.”Historically,oncologypracticeandclinicaltrialdesignprimarilyfocusedonwherethetumorfirstemerged,suchascolonorrectum,lung,breast,andendometrium.Thisapproachfollowsthelogicofthescalpel:pinpointingthelocationofthetumorfirstenabledsurgicalplans.Morerecently,therehavebeensignificantadvancesinourunderstandingoftheroleofcancerbiomarkersinmolecularandcellularmechanismsthatcandrivetumorgrowth.Biomarkersarebiologicalmolecules(typicallycomprisedofDNA,RNAorprotein)foundintissuesorbloodthatcanserveasasigntobetterunderstandaconditionordisease.Sometimes,thesamebiomarkerisfoundacrossmanydifferenttypesofcancer,regardlessofwherethetumorfirstdeveloped.Withinaspecifictumorlocation,thesebiomarkerscansometimesdifferentiatewhetherthetumorislikelytorespondtoagiventreatment.Assuch,thesebiomarkershavebeenusedtohelpinformclinicalresearch,acceleratingtheprocessofgettingtargetedmedicinestopatientswhereseparatetrialswouldtakeyearstoconduct.Importantly,insomecases,thesefeaturescanbeassessedusinglaboratoryteststhathavelongbeenavailable.Whereatestiseithernotavailable,orforresearchuseonly,thetestmanufacturerpartnerswiththedrugmanufacturertoadvancetogetherintoregulatoryapprovalbygovernmentagencies(suchastheFDA)acompaniondiagnosticassaytoensuresafeandeffectiveuseofthedruginpatientslikelytorespond.Thegoalistouseadeeperunderstandingofthetumorbiologyandassociatedbiomarkerstotackletumorresearchmoreprecisely;goingbeyondsimplywhereatumorarose.Instead,wearelearninghowtoattackacancerbasedonitsbiologyatthecellularlevel.AtMSD,effortsareunderwaytobetterunderstandmicrosatelliteinstability(MSI)andmismatchrepairdeficiency(dMMR).Thesebiomarkersarepresentacrosstumortypes,regardlessoftheoriginallocationofthecancer.ThepresenceofhighlevelsofMSI(MSI-H)ordMMRsignifiesanunderlyingprobleminacell'sabilitytofixerrorsthatoccurwhenDNAreplicates.TumorcellsdeterminedtohaveMSI-HordMMRharborhundredstothousandsofmutations.Theultimateproofofoureffortswillmanifestasanewgenerationofcancermedicines:thosethatfollowthelogicofbiology,notthelogicofthescalpel.Ourcompanyiscommittedtodiscoveringsmart,sustainablewaystoexpandaccesstohealthcare,especiallyinareaswithlimitedinfrastructureandresources.Giventhesignificanceofthischallenge,itisonlybyworkinginpartnershipwithothers—governments,donors,patientorganizations,healthcareprofessionals,NGOs,academicinstitutions,multilateralorganizationsandtheprivatesector—thatwecanwemakethestrongestcontribution.TheMSDFellowshipforGlobalHealthisbuiltonthenotionofpartneringtostrengthenthecapacityandreachofnonprofitorganizationswhich,inturn,willultimatelysolvesomeoftheworld’sgreatesthealthcarechallenges.

  In1962hercollaborators,JamesWatson,FrancisCrickandMauriceWilkinswereawardedtheNobelPrizefortheir“discoveriesconcerningthemolecularstructureofnucleicacidsanditssignificanceforinformationtransferinlivingmaterial.”Franklin’suntimelydeathdeniedhertheacclaimofthisprestigiousscientificaward(theNobelCommitteedoesnotawardtheprizeposthumously),butherroleinthisfundamentaldiscoveryhasbeenwelldocumentedandisnowwidelyrecognized.Franklin’sstoryofalifecutshortbyovariancancerremainsalltoocommon.Eventoday,advancedovariancancerremainsoneofthemostdifficultcancerstotreat.Butthereremainsareasonforoptimism.Thepaceofchangeincancertreatmenthasincreaseddramaticallyinrecentyears.Advancesinresearch–manyofwhichmaybetracedbacktoFranklin’swork–havegivenusadeeperunderstandingofhowtotargetthedisease,pavingthewayfornewdevelopments.Specifictoovariancancer,recentclinicalresearchhasshownpromiseforwomenwithadvancedstagesofthedisease.AtMSD,wearefocusedontranslatingbreakthroughscienceintooncologytherapeuticsthathavethegreatestpotentialforimprovinglong-termdiseasecontrolandsurvivalforpatients,includingthosewithovariancancer.Werecognizethatnotwopatientsorcancersarethesameandmultipleapproaches–therapeuticregimensandmechanismsofaction–willbeneededtooutpacethisdisease.That’swhywehaveworkedrigorouslytoexpandanddiversifyourowninternalresearchprograms.Thereisstillworktobedone,butwebelievestronglyinourpotentialtotransformthewayallcancersaretreated.AndweareconstantlyinspiredtoworkharderbystorieslikeRosalindFranklin’s.Dr.Chenghasbeentreatingheadandneckcancerpatientsformanyyears.Thisishispersonalperspective.Ihavetreatedpatientswithheadandneckcancersformanyyears,soIhaveseen,upclose,thedifficultexperienceoflivingwithheadandneckcancer.Cancerisatryingsituationforallpatientsandtheirlovedones,butheadandneckpatientsfacecancerinauniqueanddifficultway,withtheirdiseaseandtumorsoftenvisibletothepublic.Ihavebeeninvolvedinresearchforyearsaspartofscientists'decades-longendeavortobringforwardmeaningfuladvancesforpatientsdiagnosedwiththispotentiallyaggressivedisease.Untilrecently,suchadvanceswerehardtocomebyandmypatientsandIstruggledwiththelimitedtreatmentoptionsavailable.Butwhilethereisasignificantneedfornewtreatmentoptions,thegoodnewsisthattherehavebeensomeimprovementsinsurvivalratesovertheyearsandweareseeinganewandencouragingfutureahead.Wehavebeguntoleverageourunderstandingofbiologytodevelopmoreprecisetherapies.AtMSD,wearefocusedonimmuno-oncologyresearch,whichstudiestheroleoftheimmunesystemindetectingandfightingcancer.Wearestudyingthepotentialofthisapproach,whichaimstoharnessandrestorethebodysabilitytodetectandfightcancercells,inanumberofcancers,includingheadandneckcancer.Immuno-oncologyhasalreadysignificantlychangedthewaycertaincancersaretreated,includingmelanomaandlungcancer,aswellasinthetreatmentofheadandneckcancer.Changeiscomingtotheheadandneckcancerlandscape–anditisthrillingtobeapartofit.TobeabletoseehowourresearchandeffortsatMSDarehavingadirectimpactonhowphysiciansapproachthetreatmentoftheirpatientsandwhatpatientsmayexpectfromtheirtreatmentiswhatmotivatesustoworkharder.Chemistryhasbeencentraltoourbusinessofsinceourearliestdaysasacompany.Historically,ourdrugdiscoveryprocessprimarilycenteredaroundsmallmolecules.Then,thebirthofbiotechnologyinthelate1970s/early1980saddedbiologics,orengineeredproteins,tothemix.Today,newmodalitiesareemergingthatshowastrongpotentialtotargetcomplexdiseasesthathavenotyetbeenreachablewitheithersmallmoleculesorbiologics.RobGarbaccioisleadingatalentedteamofchemistswhoarehelpingguideMSD’sentryintothisexcitingnewfieldofmedicine.IntroducinganddiscoveringnewwaysforwardRobistheassociatevicepresident,ChemistryCapabilitiesforAcceleratingTherapeutics(CCAT),adiscoverychemistryteamthatislookingathowtogobeyondthetraditionalmethodsofdiscoveringanddevelopingmedicines."Therearecertaindiseasetargetsthatarereallyhardto'reach'andimpactusingtraditionalmethods,"henotes."SopartofthegroupIoverseetriestofigureouthowwecanemploynewermodalities,suchaspeptides,bioconjugates,andoligonucleotides,toaddressthechallengingtargetsthatareincreasinglyemergingfrombiologicalresearch."Rob'sgroupisnotfocusedonanyspecifictherapeuticarea--theyareseekingnewwaystoaddressthemostdifficultdiseasetargets."Inoncology,infectiousdiseases,andneuroscience,forexample,we’relookingforthosetargetsthatourcolleaguessay,'Ifonlywecouldmodulatethistarget,webelievewemightbeabletopotentiallyinterruptthediseaseprocessandhelppatients,'"henotes.Using‘creativechemistry’totreatdiseaseIt'scomplexwork,tobesure,butthat'swhatmakesitsointriguingandinspiringforRobandhisteam."ThethingthatIlikethemostaboutmyworkisthebeliefthattheremaybeapathforwardforthetreatmentofeachandeveryoneofthesediseases.Wejustcan'tseeityetbecausethebiologyissocomplex,"saysRob."Asresearcherscontinuetoimproveourunderstandingofdiseasebiology,Ibelievethatcombiningthatknowledgewithcreativechemistrywillhelpleadusdownnewroadstotreatingdiseaseandhelpingpatients."Robjoinedthecompanyaftercompletinggraduateschoolandapostdoctoralfellowshipfocusingonorganicchemistry."Icameherebecausescienceandinnovationdrivethiscompany.I'mpassionateaboutourmissiontosaveandimprovelives,andIbelievethatmybestdayatwork,thedaymyteammakesapotentiallylife-changingdiscovery,isstillaheadofme,andit'sthereasonthatIstay."InventingforlifeAtMSD,wesayweare.AndRobdefinitelyseeshimselfasaninventor."Chemistshavethisuniqueabilitytocombineatomsandbondsbetweenatomsinauniqueway.Everydaychemistsareinventinghundredsofmoleculesthathaveneverexistedbefore.So,yes,weareinventing,"hesays."Weareinventingtosolveproblems."

  Ourcompanyiscommittedtodiscoveringsmart,sustainablewaystoexpandaccesstohealthcare,especiallyinareaswithlimitedinfrastructureandresources.Giventhesignificanceofthischallenge,itisonlybyworkinginpartnershipwithothers—governments,donors,patientorganizations,healthcareprofessionals,NGOs,academicinstitutions,multilateralorganizationsandtheprivatesector—thatwecanwemakethestrongestcontribution.TheMSDFellowshipforGlobalHealthisbuiltonthenotionofpartneringtostrengthenthecapacityandreachofnonprofitorganizationswhich,inturn,willultimatelysolvesomeoftheworld’sgreatesthealthcarechallenges.Chemistryhasbeencentraltoourbusinessofsinceourearliestdaysasacompany.Historically,ourdrugdiscoveryprocessprimarilycenteredaroundsmallmolecules.Then,thebirthofbiotechnologyinthelate1970s/early1980saddedbiologics,orengineeredproteins,tothemix.Today,newmodalitiesareemergingthatshowastrongpotentialtotargetcomplexdiseasesthathavenotyetbeenreachablewitheithersmallmoleculesorbiologics.RobGarbaccioisleadingatalentedteamofchemistswhoarehelpingguideMSD’sentryintothisexcitingnewfieldofmedicine.IntroducinganddiscoveringnewwaysforwardRobistheassociatevicepresident,ChemistryCapabilitiesforAcceleratingTherapeutics(CCAT),adiscoverychemistryteamthatislookingathowtogobeyondthetraditionalmethodsofdiscoveringanddevelopingmedicines."Therearecertaindiseasetargetsthatarereallyhardto'reach'andimpactusingtraditionalmethods,"henotes."SopartofthegroupIoverseetriestofigureouthowwecanemploynewermodalities,suchaspeptides,bioconjugates,andoligonucleotides,toaddressthechallengingtargetsthatareincreasinglyemergingfrombiologicalresearch."Rob'sgroupisnotfocusedonanyspecifictherapeuticarea--theyareseekingnewwaystoaddressthemostdifficultdiseasetargets."Inoncology,infectiousdiseases,andneuroscience,forexample,we’relookingforthosetargetsthatourcolleaguessay,'Ifonlywecouldmodulatethistarget,webelievewemightbeabletopotentiallyinterruptthediseaseprocessandhelppatients,'"henotes.Using‘creativechemistry’totreatdiseaseIt'scomplexwork,tobesure,butthat'swhatmakesitsointriguingandinspiringforRobandhisteam."ThethingthatIlikethemostaboutmyworkisthebeliefthattheremaybeapathforwardforthetreatmentofeachandeveryoneofthesediseases.Wejustcan'tseeityetbecausethebiologyissocomplex,"saysRob."Asresearcherscontinuetoimproveourunderstandingofdiseasebiology,Ibelievethatcombiningthatknowledgewithcreativechemistrywillhelpleadusdownnewroadstotreatingdiseaseandhelpingpatients."Robjoinedthecompanyaftercompletinggraduateschoolandapostdoctoralfellowshipfocusingonorganicchemistry."Icameherebecausescienceandinnovationdrivethiscompany.I'mpassionateaboutourmissiontosaveandimprovelives,andIbelievethatmybestdayatwork,thedaymyteammakesapotentiallylife-changingdiscovery,isstillaheadofme,andit'sthereasonthatIstay."InventingforlifeAtMSD,wesayweare.AndRobdefinitelyseeshimselfasaninventor."Chemistshavethisuniqueabilitytocombineatomsandbondsbetweenatomsinauniqueway.Everydaychemistsareinventinghundredsofmoleculesthathaveneverexistedbefore.So,yes,weareinventing,"hesays."Weareinventingtosolveproblems."CarolineFox,M.D.ispassionateaboutgenetics.Inmedicalschool,shestudiedtheeffectsoftheenvironmentondiabetesandobesityonatribeofNativeAmericans(certainpopulationsworldwidehaveagreaterpropensitytowardsdiabetes;thistribewasonesuchgroup).Herresearchlefthermotivatedtolearnmoreabouthowgeneticsplaysaroleinmetabolicdiseases.Thatwasmystart,shenotes.Sincethen,almostallofmyresearchhasbeenfocusedonuncoveringthegeneticfoundationsofthesetypesofdiseases.ChangingPerceptionsPriortojoiningMSDResearchLaboratoriesinBoston,CarolineworkedattheNationalInstitutesofHealth.There,sheledalabthatstudiedmetabolicriskfactorsforcardiovasculardiseaseaspartofthe,apioneeringlong-termpopulationstudyofcardiovasculardisease.But,shenotes,theshifttoMSDwasarelativelyeasyone.IwasimpressedbyMSDseffortstoleveragehumangeneticstodrivedrugdiscovery,shesays.Forme,itwastheperfectnextstepfromtheworkthatIhadbeendoinginacademia.Genetics:TheNewFrontierWe'relucky—CarolinespassionforgeneticsisagreatfitforMSD.Inourlabsandacrosstheindustry,weareseeinganincreaseduseofhumangeneticstohelpdeterminewhetherpatientswillrespondtoacertaindrugornot,ShepointstoMSD'sactiveresearchcollaborationswithscientistsaroundtheworldaimedatadvancingthisfieldofscience.Iamveryenthusiasticaboutwhereourresearchmaylead.

  CarolineFox,M.D.ispassionateaboutgenetics.Inmedicalschool,shestudiedtheeffectsoftheenvironmentondiabetesandobesityonatribeofNativeAmericans(certainpopulationsworldwidehaveagreaterpropensitytowardsdiabetes;thistribewasonesuchgroup).Herresearchlefthermotivatedtolearnmoreabouthowgeneticsplaysaroleinmetabolicdiseases.Thatwasmystart,shenotes.Sincethen,almostallofmyresearchhasbeenfocusedonuncoveringthegeneticfoundationsofthesetypesofdiseases.ChangingPerceptionsPriortojoiningMSDResearchLaboratoriesinBoston,CarolineworkedattheNationalInstitutesofHealth.There,sheledalabthatstudiedmetabolicriskfactorsforcardiovasculardiseaseaspartofthe,apioneeringlong-termpopulationstudyofcardiovasculardisease.But,shenotes,theshifttoMSDwasarelativelyeasyone.IwasimpressedbyMSDseffortstoleveragehumangeneticstodrivedrugdiscovery,shesays.Forme,itwastheperfectnextstepfromtheworkthatIhadbeendoinginacademia.Genetics:TheNewFrontierWe'relucky—CarolinespassionforgeneticsisagreatfitforMSD.Inourlabsandacrosstheindustry,weareseeinganincreaseduseofhumangeneticstohelpdeterminewhetherpatientswillrespondtoacertaindrugornot,ShepointstoMSD'sactiveresearchcollaborationswithscientistsaroundtheworldaimedatadvancingthisfieldofscience.Iamveryenthusiasticaboutwhereourresearchmaylead.Chemistryhasbeencentraltoourbusinessofsinceourearliestdaysasacompany.Historically,ourdrugdiscoveryprocessprimarilycenteredaroundsmallmolecules.Then,thebirthofbiotechnologyinthelate1970s/early1980saddedbiologics,orengineeredproteins,tothemix.Today,newmodalitiesareemergingthatshowastrongpotentialtotargetcomplexdiseasesthathavenotyetbeenreachablewitheithersmallmoleculesorbiologics.RobGarbaccioisleadingatalentedteamofchemistswhoarehelpingguideMSD’sentryintothisexcitingnewfieldofmedicine.IntroducinganddiscoveringnewwaysforwardRobistheassociatevicepresident,ChemistryCapabilitiesforAcceleratingTherapeutics(CCAT),adiscoverychemistryteamthatislookingathowtogobeyondthetraditionalmethodsofdiscoveringanddevelopingmedicines."Therearecertaindiseasetargetsthatarereallyhardto'reach'andimpactusingtraditionalmethods,"henotes."SopartofthegroupIoverseetriestofigureouthowwecanemploynewermodalities,suchaspeptides,bioconjugates,andoligonucleotides,toaddressthechallengingtargetsthatareincreasinglyemergingfrombiologicalresearch."Rob'sgroupisnotfocusedonanyspecifictherapeuticarea--theyareseekingnewwaystoaddressthemostdifficultdiseasetargets."Inoncology,infectiousdiseases,andneuroscience,forexample,we’relookingforthosetargetsthatourcolleaguessay,'Ifonlywecouldmodulatethistarget,webelievewemightbeabletopotentiallyinterruptthediseaseprocessandhelppatients,'"henotes.Using‘creativechemistry’totreatdiseaseIt'scomplexwork,tobesure,butthat'swhatmakesitsointriguingandinspiringforRobandhisteam."ThethingthatIlikethemostaboutmyworkisthebeliefthattheremaybeapathforwardforthetreatmentofeachandeveryoneofthesediseases.Wejustcan'tseeityetbecausethebiologyissocomplex,"saysRob."Asresearcherscontinuetoimproveourunderstandingofdiseasebiology,Ibelievethatcombiningthatknowledgewithcreativechemistrywillhelpleadusdownnewroadstotreatingdiseaseandhelpingpatients."Robjoinedthecompanyaftercompletinggraduateschoolandapostdoctoralfellowshipfocusingonorganicchemistry."Icameherebecausescienceandinnovationdrivethiscompany.I'mpassionateaboutourmissiontosaveandimprovelives,andIbelievethatmybestdayatwork,thedaymyteammakesapotentiallylife-changingdiscovery,isstillaheadofme,andit'sthereasonthatIstay."InventingforlifeAtMSD,wesayweare.AndRobdefinitelyseeshimselfasaninventor."Chemistshavethisuniqueabilitytocombineatomsandbondsbetweenatomsinauniqueway.Everydaychemistsareinventinghundredsofmoleculesthathaveneverexistedbefore.So,yes,weareinventing,"hesays."Weareinventingtosolveproblems."“MyuncleIvanwasaseverediabetespatient—heneededinjectionsthreetimesaday.Hewaswithoutinsulinformorethanamonth.EvenIwasnotaware,”Pablorecounts.“Whenhefinallyreceivedinsulin,hewasinbadcondition.Severalweekslater,hishealthdeclined,hehadrenalfailure,andhedied.”ThedroneteamrecentlyacknowledgedPablo’scontributions,andhispersonalloss,bygivingtheprojectanewnickname.Oncecalled“MajorTom”aftertheDavidBowiesong,it’snow“ProjectIvan.”“Idon’thavewordsenoughtoshowmygratitude,”Pablosays.“Thisisaboutsavinglives.”

  Dr.Chenghasbeentreatingheadandneckcancerpatientsformanyyears.Thisishispersonalperspective.Ihavetreatedpatientswithheadandneckcancersformanyyears,soIhaveseen,upclose,thedifficultexperienceoflivingwithheadandneckcancer.Cancerisatryingsituationforallpatientsandtheirlovedones,butheadandneckpatientsfacecancerinauniqueanddifficultway,withtheirdiseaseandtumorsoftenvisibletothepublic.Ihavebeeninvolvedinresearchforyearsaspartofscientists'decades-longendeavortobringforwardmeaningfuladvancesforpatientsdiagnosedwiththispotentiallyaggressivedisease.Untilrecently,suchadvanceswerehardtocomebyandmypatientsandIstruggledwiththelimitedtreatmentoptionsavailable.Butwhilethereisasignificantneedfornewtreatmentoptions,thegoodnewsisthattherehavebeensomeimprovementsinsurvivalratesovertheyearsandweareseeinganewandencouragingfutureahead.Wehavebeguntoleverageourunderstandingofbiologytodevelopmoreprecisetherapies.AtMSD,wearefocusedonimmuno-oncologyresearch,whichstudiestheroleoftheimmunesystemindetectingandfightingcancer.Wearestudyingthepotentialofthisapproach,whichaimstoharnessandrestorethebodysabilitytodetectandfightcancercells,inanumberofcancers,includingheadandneckcancer.Immuno-oncologyhasalreadysignificantlychangedthewaycertaincancersaretreated,includingmelanomaandlungcancer,aswellasinthetreatmentofheadandneckcancer.Changeiscomingtotheheadandneckcancerlandscape–anditisthrillingtobeapartofit.TobeabletoseehowourresearchandeffortsatMSDarehavingadirectimpactonhowphysiciansapproachthetreatmentoftheirpatientsandwhatpatientsmayexpectfromtheirtreatmentiswhatmotivatesustoworkharder.“MyuncleIvanwasaseverediabetespatient—heneededinjectionsthreetimesaday.Hewaswithoutinsulinformorethanamonth.EvenIwasnotaware,”Pablorecounts.“Whenhefinallyreceivedinsulin,hewasinbadcondition.Severalweekslater,hishealthdeclined,hehadrenalfailure,andhedied.”ThedroneteamrecentlyacknowledgedPablo’scontributions,andhispersonalloss,bygivingtheprojectanewnickname.Oncecalled“MajorTom”aftertheDavidBowiesong,it’snow“ProjectIvan.”“Idon’thavewordsenoughtoshowmygratitude,”Pablosays.“Thisisaboutsavinglives.”“MyuncleIvanwasaseverediabetespatient—heneededinjectionsthreetimesaday.Hewaswithoutinsulinformorethanamonth.EvenIwasnotaware,”Pablorecounts.“Whenhefinallyreceivedinsulin,hewasinbadcondition.Severalweekslater,hishealthdeclined,hehadrenalfailure,andhedied.”ThedroneteamrecentlyacknowledgedPablo’scontributions,andhispersonalloss,bygivingtheprojectanewnickname.Oncecalled“MajorTom”aftertheDavidBowiesong,it’snow“ProjectIvan.”“Idon’thavewordsenoughtoshowmygratitude,”Pablosays.“Thisisaboutsavinglives.”

  Historically,oncologypracticeandclinicaltrialdesignprimarilyfocusedonwherethetumorfirstemerged,suchascolonorrectum,lung,breast,andendometrium.Thisapproachfollowsthelogicofthescalpel:pinpointingthelocationofthetumorfirstenabledsurgicalplans.Morerecently,therehavebeensignificantadvancesinourunderstandingoftheroleofcancerbiomarkersinmolecularandcellularmechanismsthatcandrivetumorgrowth.Biomarkersarebiologicalmolecules(typicallycomprisedofDNA,RNAorprotein)foundintissuesorbloodthatcanserveasasigntobetterunderstandaconditionordisease.Sometimes,thesamebiomarkerisfoundacrossmanydifferenttypesofcancer,regardlessofwherethetumorfirstdeveloped.Withinaspecifictumorlocation,thesebiomarkerscansometimesdifferentiatewhetherthetumorislikelytorespondtoagiventreatment.Assuch,thesebiomarkershavebeenusedtohelpinformclinicalresearch,acceleratingtheprocessofgettingtargetedmedicinestopatientswhereseparatetrialswouldtakeyearstoconduct.Importantly,insomecases,thesefeaturescanbeassessedusinglaboratoryteststhathavelongbeenavailable.Whereatestiseithernotavailable,orforresearchuseonly,thetestmanufacturerpartnerswiththedrugmanufacturertoadvancetogetherintoregulatoryapprovalbygovernmentagencies(suchastheFDA)acompaniondiagnosticassaytoensuresafeandeffectiveuseofthedruginpatientslikelytorespond.Thegoalistouseadeeperunderstandingofthetumorbiologyandassociatedbiomarkerstotackletumorresearchmoreprecisely;goingbeyondsimplywhereatumorarose.Instead,wearelearninghowtoattackacancerbasedonitsbiologyatthecellularlevel.AtMSD,effortsareunderwaytobetterunderstandmicrosatelliteinstability(MSI)andmismatchrepairdeficiency(dMMR).Thesebiomarkersarepresentacrosstumortypes,regardlessoftheoriginallocationofthecancer.ThepresenceofhighlevelsofMSI(MSI-H)ordMMRsignifiesanunderlyingprobleminacell'sabilitytofixerrorsthatoccurwhenDNAreplicates.TumorcellsdeterminedtohaveMSI-HordMMRharborhundredstothousandsofmutations.Theultimateproofofoureffortswillmanifestasanewgenerationofcancermedicines:thosethatfollowthelogicofbiology,notthelogicofthescalpel.Jameslikeslogicpuzzles.Andwordproblems.Luckily,hegetstoapplytheseinterestsinhisworkeveryday.Jamesisacomputationalchemist–heworkswithMSD’schemistryteams,applyingpredictivemodellingtoidentifywaystodesigndrugsandanalyzedatatohelpourscientistsprioritizethenextcompoundstomakeandtest.Althoughthesearecomplexproblemsandcomplexquestionsthatwe’retryingtosolve,wetakelogicalsteps,explainsJames.Foreveryquestion,there’sreallyananswer,yousometimesjusthavetospendalittlebitmoretimethinkingaboutit,andtakeastepbackandlookatwhat’sactuallyinfrontofyou.Bettermolecules,fasterInourgroup’sroleindrugdiscovery,wehavethismantraof‘bettermolecules,faster,saysJames.Ifachemisthas100compoundsthatshe’sthinkingaboutmaking,computationally,wecanhelpprioritizewhichonestostartwithbasedonrationaldrugdesign.Jamesenjoysbeingpartofateamworkingtoachieveasingulargoal:tocreatemedicinesthatwillhelpthepeoplewhoneedthem.And,hebelievesthatcollaborationisveryimportantforresearchanddevelopment:Youcan'tdoaprojectonyourown;youneedotherstoassistandhelp,notjustbycontributingintheirindividualrole,butalsowiththeirthinking.Jamesandhiscolleagueshavealotofexperiencewithperseveranceanddetermination,too.Ourteamsofscientistsdesign,developandscreenthousandsofcompoundsandantibodiestoultimatelyadvanceonlyafewofthemostpromisingleadcandidatesintoclinicaltesting.Moleculardesignanddevelopmentisaniterativeprocess.Youhavetostickwithit.It'scontinuouslymakingmodificationsandadaptingandevolving,eventuallygettingdowntheroadorthepipelinetomakeadrug…that'swhat'sexcitingaboutit.It’sallaboutthepatientsEveryday,IcometoworkknowingthatI’mworkingtomakeadrug.And,Idon'tknowiftodayI’mgoingtoopenupanemailwithresultssaying,‘we'veaccomplishedthisor‘weneedtochangethat.’Butregardlessofwhatthoseresultsare,it'sgoingtobeprogresstogettothatendpoint.”CarolineFox,M.D.ispassionateaboutgenetics.Inmedicalschool,shestudiedtheeffectsoftheenvironmentondiabetesandobesityonatribeofNativeAmericans(certainpopulationsworldwidehaveagreaterpropensitytowardsdiabetes;thistribewasonesuchgroup).Herresearchlefthermotivatedtolearnmoreabouthowgeneticsplaysaroleinmetabolicdiseases.Thatwasmystart,shenotes.Sincethen,almostallofmyresearchhasbeenfocusedonuncoveringthegeneticfoundationsofthesetypesofdiseases.ChangingPerceptionsPriortojoiningMSDResearchLaboratoriesinBoston,CarolineworkedattheNationalInstitutesofHealth.There,sheledalabthatstudiedmetabolicriskfactorsforcardiovasculardiseaseaspartofthe,apioneeringlong-termpopulationstudyofcardiovasculardisease.But,shenotes,theshifttoMSDwasarelativelyeasyone.IwasimpressedbyMSDseffortstoleveragehumangeneticstodrivedrugdiscovery,shesays.Forme,itwastheperfectnextstepfromtheworkthatIhadbeendoinginacademia.Genetics:TheNewFrontierWe'relucky—CarolinespassionforgeneticsisagreatfitforMSD.Inourlabsandacrosstheindustry,weareseeinganincreaseduseofhumangeneticstohelpdeterminewhetherpatientswillrespondtoacertaindrugornot,ShepointstoMSD'sactiveresearchcollaborationswithscientistsaroundtheworldaimedatadvancingthisfieldofscience.Iamveryenthusiasticaboutwhereourresearchmaylead.

  CarolineFox,M.D.ispassionateaboutgenetics.Inmedicalschool,shestudiedtheeffectsoftheenvironmentondiabetesandobesityonatribeofNativeAmericans(certainpopulationsworldwidehaveagreaterpropensitytowardsdiabetes;thistribewasonesuchgroup).Herresearchlefthermotivatedtolearnmoreabouthowgeneticsplaysaroleinmetabolicdiseases.Thatwasmystart,shenotes.Sincethen,almostallofmyresearchhasbeenfocusedonuncoveringthegeneticfoundationsofthesetypesofdiseases.ChangingPerceptionsPriortojoiningMSDResearchLaboratoriesinBoston,CarolineworkedattheNationalInstitutesofHealth.There,sheledalabthatstudiedmetabolicriskfactorsforcardiovasculardiseaseaspartofthe,apioneeringlong-termpopulationstudyofcardiovasculardisease.But,shenotes,theshifttoMSDwasarelativelyeasyone.IwasimpressedbyMSDseffortstoleveragehumangeneticstodrivedrugdiscovery,shesays.Forme,itwastheperfectnextstepfromtheworkthatIhadbeendoinginacademia.Genetics:TheNewFrontierWe'relucky—CarolinespassionforgeneticsisagreatfitforMSD.Inourlabsandacrosstheindustry,weareseeinganincreaseduseofhumangeneticstohelpdeterminewhetherpatientswillrespondtoacertaindrugornot,ShepointstoMSD'sactiveresearchcollaborationswithscientistsaroundtheworldaimedatadvancingthisfieldofscience.Iamveryenthusiasticaboutwhereourresearchmaylead.Jameslikeslogicpuzzles.Andwordproblems.Luckily,hegetstoapplytheseinterestsinhisworkeveryday.Jamesisacomputationalchemist–heworkswithMSD’schemistryteams,applyingpredictivemodellingtoidentifywaystodesigndrugsandanalyzedatatohelpourscientistsprioritizethenextcompoundstomakeandtest.Althoughthesearecomplexproblemsandcomplexquestionsthatwe’retryingtosolve,wetakelogicalsteps,explainsJames.Foreveryquestion,there’sreallyananswer,yousometimesjusthavetospendalittlebitmoretimethinkingaboutit,andtakeastepbackandlookatwhat’sactuallyinfrontofyou.Bettermolecules,fasterInourgroup’sroleindrugdiscovery,wehavethismantraof‘bettermolecules,faster,saysJames.Ifachemisthas100compoundsthatshe’sthinkingaboutmaking,computationally,wecanhelpprioritizewhichonestostartwithbasedonrationaldrugdesign.Jamesenjoysbeingpartofateamworkingtoachieveasingulargoal:tocreatemedicinesthatwillhelpthepeoplewhoneedthem.And,hebelievesthatcollaborationisveryimportantforresearchanddevelopment:Youcan'tdoaprojectonyourown;youneedotherstoassistandhelp,notjustbycontributingintheirindividualrole,butalsowiththeirthinking.Jamesandhiscolleagueshavealotofexperiencewithperseveranceanddetermination,too.Ourteamsofscientistsdesign,developandscreenthousandsofcompoundsandantibodiestoultimatelyadvanceonlyafewofthemostpromisingleadcandidatesintoclinicaltesting.Moleculardesignanddevelopmentisaniterativeprocess.Youhavetostickwithit.It'scontinuouslymakingmodificationsandadaptingandevolving,eventuallygettingdowntheroadorthepipelinetomakeadrug…that'swhat'sexcitingaboutit.It’sallaboutthepatientsEveryday,IcometoworkknowingthatI’mworkingtomakeadrug.And,Idon'tknowiftodayI’mgoingtoopenupanemailwithresultssaying,‘we'veaccomplishedthisor‘weneedtochangethat.’Butregardlessofwhatthoseresultsare,it'sgoingtobeprogresstogettothatendpoint.”CarolineFox,M.D.ispassionateaboutgenetics.Inmedicalschool,shestudiedtheeffectsoftheenvironmentondiabetesandobesityonatribeofNativeAmericans(certainpopulationsworldwidehaveagreaterpropensitytowardsdiabetes;thistribewasonesuchgroup).Herresearchlefthermotivatedtolearnmoreabouthowgeneticsplaysaroleinmetabolicdiseases.Thatwasmystart,shenotes.Sincethen,almostallofmyresearchhasbeenfocusedonuncoveringthegeneticfoundationsofthesetypesofdiseases.ChangingPerceptionsPriortojoiningMSDResearchLaboratoriesinBoston,CarolineworkedattheNationalInstitutesofHealth.There,sheledalabthatstudiedmetabolicriskfactorsforcardiovasculardiseaseaspartofthe,apioneeringlong-termpopulationstudyofcardiovasculardisease.But,shenotes,theshifttoMSDwasarelativelyeasyone.IwasimpressedbyMSDseffortstoleveragehumangeneticstodrivedrugdiscovery,shesays.Forme,itwastheperfectnextstepfromtheworkthatIhadbeendoinginacademia.Genetics:TheNewFrontierWe'relucky—CarolinespassionforgeneticsisagreatfitforMSD.Inourlabsandacrosstheindustry,weareseeinganincreaseduseofhumangeneticstohelpdeterminewhetherpatientswillrespondtoacertaindrugornot,ShepointstoMSD'sactiveresearchcollaborationswithscientistsaroundtheworldaimedatadvancingthisfieldofscience.Iamveryenthusiasticaboutwhereourresearchmaylead.

  “MyuncleIvanwasaseverediabetespatient—heneededinjectionsthreetimesaday.Hewaswithoutinsulinformorethanamonth.EvenIwasnotaware,”Pablorecounts.“Whenhefinallyreceivedinsulin,hewasinbadcondition.Severalweekslater,hishealthdeclined,hehadrenalfailure,andhedied.”ThedroneteamrecentlyacknowledgedPablo’scontributions,andhispersonalloss,bygivingtheprojectanewnickname.Oncecalled“MajorTom”aftertheDavidBowiesong,it’snow“ProjectIvan.”“Idon’thavewordsenoughtoshowmygratitude,”Pablosays.“Thisisaboutsavinglives.”Chemistryhasbeencentraltoourbusinessofsinceourearliestdaysasacompany.Historically,ourdrugdiscoveryprocessprimarilycenteredaroundsmallmolecules.Then,thebirthofbiotechnologyinthelate1970s/early1980saddedbiologics,orengineeredproteins,tothemix.Today,newmodalitiesareemergingthatshowastrongpotentialtotargetcomplexdiseasesthathavenotyetbeenreachablewitheithersmallmoleculesorbiologics.RobGarbaccioisleadingatalentedteamofchemistswhoarehelpingguideMSD’sentryintothisexcitingnewfieldofmedicine.IntroducinganddiscoveringnewwaysforwardRobistheassociatevicepresident,ChemistryCapabilitiesforAcceleratingTherapeutics(CCAT),adiscoverychemistryteamthatislookingathowtogobeyondthetraditionalmethodsofdiscoveringanddevelopingmedicines."Therearecertaindiseasetargetsthatarereallyhardto'reach'andimpactusingtraditionalmethods,"henotes."SopartofthegroupIoverseetriestofigureouthowwecanemploynewermodalities,suchaspeptides,bioconjugates,andoligonucleotides,toaddressthechallengingtargetsthatareincreasinglyemergingfrombiologicalresearch."Rob'sgroupisnotfocusedonanyspecifictherapeuticarea--theyareseekingnewwaystoaddressthemostdifficultdiseasetargets."Inoncology,infectiousdiseases,andneuroscience,forexample,we’relookingforthosetargetsthatourcolleaguessay,'Ifonlywecouldmodulatethistarget,webelievewemightbeabletopotentiallyinterruptthediseaseprocessandhelppatients,'"henotes.Using‘creativechemistry’totreatdiseaseIt'scomplexwork,tobesure,butthat'swhatmakesitsointriguingandinspiringforRobandhisteam."ThethingthatIlikethemostaboutmyworkisthebeliefthattheremaybeapathforwardforthetreatmentofeachandeveryoneofthesediseases.Wejustcan'tseeityetbecausethebiologyissocomplex,"saysRob."Asresearcherscontinuetoimproveourunderstandingofdiseasebiology,Ibelievethatcombiningthatknowledgewithcreativechemistrywillhelpleadusdownnewroadstotreatingdiseaseandhelpingpatients."Robjoinedthecompanyaftercompletinggraduateschoolandapostdoctoralfellowshipfocusingonorganicchemistry."Icameherebecausescienceandinnovationdrivethiscompany.I'mpassionateaboutourmissiontosaveandimprovelives,andIbelievethatmybestdayatwork,thedaymyteammakesapotentiallylife-changingdiscovery,isstillaheadofme,andit'sthereasonthatIstay."InventingforlifeAtMSD,wesayweare.AndRobdefinitelyseeshimselfasaninventor."Chemistshavethisuniqueabilitytocombineatomsandbondsbetweenatomsinauniqueway.Everydaychemistsareinventinghundredsofmoleculesthathaveneverexistedbefore.So,yes,weareinventing,"hesays."Weareinventingtosolveproblems."“MyuncleIvanwasaseverediabetespatient—heneededinjectionsthreetimesaday.Hewaswithoutinsulinformorethanamonth.EvenIwasnotaware,”Pablorecounts.“Whenhefinallyreceivedinsulin,hewasinbadcondition.Severalweekslater,hishealthdeclined,hehadrenalfailure,andhedied.”ThedroneteamrecentlyacknowledgedPablo’scontributions,andhispersonalloss,bygivingtheprojectanewnickname.Oncecalled“MajorTom”aftertheDavidBowiesong,it’snow“ProjectIvan.”“Idon’thavewordsenoughtoshowmygratitude,”Pablosays.“Thisisaboutsavinglives.”

  Jameslikeslogicpuzzles.Andwordproblems.Luckily,hegetstoapplytheseinterestsinhisworkeveryday.Jamesisacomputationalchemist–heworkswithMSD’schemistryteams,applyingpredictivemodellingtoidentifywaystodesigndrugsandanalyzedatatohelpourscientistsprioritizethenextcompoundstomakeandtest.Althoughthesearecomplexproblemsandcomplexquestionsthatwe’retryingtosolve,wetakelogicalsteps,explainsJames.Foreveryquestion,there’sreallyananswer,yousometimesjusthavetospendalittlebitmoretimethinkingaboutit,andtakeastepbackandlookatwhat’sactuallyinfrontofyou.Bettermolecules,fasterInourgroup’sroleindrugdiscovery,wehavethismantraof‘bettermolecules,faster,saysJames.Ifachemisthas100compoundsthatshe’sthinkingaboutmaking,computationally,wecanhelpprioritizewhichonestostartwithbasedonrationaldrugdesign.Jamesenjoysbeingpartofateamworkingtoachieveasingulargoal:tocreatemedicinesthatwillhelpthepeoplewhoneedthem.And,hebelievesthatcollaborationisveryimportantforresearchanddevelopment:Youcan'tdoaprojectonyourown;youneedotherstoassistandhelp,notjustbycontributingintheirindividualrole,butalsowiththeirthinking.Jamesandhiscolleagueshavealotofexperiencewithperseveranceanddetermination,too.Ourteamsofscientistsdesign,developandscreenthousandsofcompoundsandantibodiestoultimatelyadvanceonlyafewofthemostpromisingleadcandidatesintoclinicaltesting.Moleculardesignanddevelopmentisaniterativeprocess.Youhavetostickwithit.It'scontinuouslymakingmodificationsandadaptingandevolving,eventuallygettingdowntheroadorthepipelinetomakeadrug…that'swhat'sexcitingaboutit.It’sallaboutthepatientsEveryday,IcometoworkknowingthatI’mworkingtomakeadrug.And,Idon'tknowiftodayI’mgoingtoopenupanemailwithresultssaying,‘we'veaccomplishedthisor‘weneedtochangethat.’Butregardlessofwhatthoseresultsare,it'sgoingtobeprogresstogettothatendpoint.”Ourcompanyiscommittedtodiscoveringsmart,sustainablewaystoexpandaccesstohealthcare,especiallyinareaswithlimitedinfrastructureandresources.Giventhesignificanceofthischallenge,itisonlybyworkinginpartnershipwithothers—governments,donors,patientorganizations,healthcareprofessionals,NGOs,academicinstitutions,multilateralorganizationsandtheprivatesector—thatwecanwemakethestrongestcontribution.TheMSDFellowshipforGlobalHealthisbuiltonthenotionofpartneringtostrengthenthecapacityandreachofnonprofitorganizationswhich,inturn,willultimatelysolvesomeoftheworld’sgreatesthealthcarechallenges.Jameslikeslogicpuzzles.Andwordproblems.Luckily,hegetstoapplytheseinterestsinhisworkeveryday.Jamesisacomputationalchemist–heworkswithMSD’schemistryteams,applyingpredictivemodellingtoidentifywaystodesigndrugsandanalyzedatatohelpourscientistsprioritizethenextcompoundstomakeandtest.Althoughthesearecomplexproblemsandcomplexquestionsthatwe’retryingtosolve,wetakelogicalsteps,explainsJames.Foreveryquestion,there’sreallyananswer,yousometimesjusthavetospendalittlebitmoretimethinkingaboutit,andtakeastepbackandlookatwhat’sactuallyinfrontofyou.Bettermolecules,fasterInourgroup’sroleindrugdiscovery,wehavethismantraof‘bettermolecules,faster,saysJames.Ifachemisthas100compoundsthatshe’sthinkingaboutmaking,computationally,wecanhelpprioritizewhichonestostartwithbasedonrationaldrugdesign.Jamesenjoysbeingpartofateamworkingtoachieveasingulargoal:tocreatemedicinesthatwillhelpthepeoplewhoneedthem.And,hebelievesthatcollaborationisveryimportantforresearchanddevelopment:Youcan'tdoaprojectonyourown;youneedotherstoassistandhelp,notjustbycontributingintheirindividualrole,butalsowiththeirthinking.Jamesandhiscolleagueshavealotofexperiencewithperseveranceanddetermination,too.Ourteamsofscientistsdesign,developandscreenthousandsofcompoundsandantibodiestoultimatelyadvanceonlyafewofthemostpromisingleadcandidatesintoclinicaltesting.Moleculardesignanddevelopmentisaniterativeprocess.Youhavetostickwithit.It'scontinuouslymakingmodificationsandadaptingandevolving,eventuallygettingdowntheroadorthepipelinetomakeadrug…that'swhat'sexcitingaboutit.It’sallaboutthepatientsEveryday,IcometoworkknowingthatI’mworkingtomakeadrug.And,Idon'tknowiftodayI’mgoingtoopenupanemailwithresultssaying,‘we'veaccomplishedthisor‘weneedtochangethat.’Butregardlessofwhatthoseresultsare,it'sgoingtobeprogresstogettothatendpoint.”

  Chemistryhasbeencentraltoourbusinessofsinceourearliestdaysasacompany.Historically,ourdrugdiscoveryprocessprimarilycenteredaroundsmallmolecules.Then,thebirthofbiotechnologyinthelate1970s/early1980saddedbiologics,orengineeredproteins,tothemix.Today,newmodalitiesareemergingthatshowastrongpotentialtotargetcomplexdiseasesthathavenotyetbeenreachablewitheithersmallmoleculesorbiologics.RobGarbaccioisleadingatalentedteamofchemistswhoarehelpingguideMSD’sentryintothisexcitingnewfieldofmedicine.IntroducinganddiscoveringnewwaysforwardRobistheassociatevicepresident,ChemistryCapabilitiesforAcceleratingTherapeutics(CCAT),adiscoverychemistryteamthatislookingathowtogobeyondthetraditionalmethodsofdiscoveringanddevelopingmedicines."Therearecertaindiseasetargetsthatarereallyhardto'reach'andimpactusingtraditionalmethods,"henotes."SopartofthegroupIoverseetriestofigureouthowwecanemploynewermodalities,suchaspeptides,bioconjugates,andoligonucleotides,toaddressthechallengingtargetsthatareincreasinglyemergingfrombiologicalresearch."Rob'sgroupisnotfocusedonanyspecifictherapeuticarea--theyareseekingnewwaystoaddressthemostdifficultdiseasetargets."Inoncology,infectiousdiseases,andneuroscience,forexample,we’relookingforthosetargetsthatourcolleaguessay,'Ifonlywecouldmodulatethistarget,webelievewemightbeabletopotentiallyinterruptthediseaseprocessandhelppatients,'"henotes.Using‘creativechemistry’totreatdiseaseIt'scomplexwork,tobesure,butthat'swhatmakesitsointriguingandinspiringforRobandhisteam."ThethingthatIlikethemostaboutmyworkisthebeliefthattheremaybeapathforwardforthetreatmentofeachandeveryoneofthesediseases.Wejustcan'tseeityetbecausethebiologyissocomplex,"saysRob."Asresearcherscontinuetoimproveourunderstandingofdiseasebiology,Ibelievethatcombiningthatknowledgewithcreativechemistrywillhelpleadusdownnewroadstotreatingdiseaseandhelpingpatients."Robjoinedthecompanyaftercompletinggraduateschoolandapostdoctoralfellowshipfocusingonorganicchemistry."Icameherebecausescienceandinnovationdrivethiscompany.I'mpassionateaboutourmissiontosaveandimprovelives,andIbelievethatmybestdayatwork,thedaymyteammakesapotentiallylife-changingdiscovery,isstillaheadofme,andit'sthereasonthatIstay."InventingforlifeAtMSD,wesayweare.AndRobdefinitelyseeshimselfasaninventor."Chemistshavethisuniqueabilitytocombineatomsandbondsbetweenatomsinauniqueway.Everydaychemistsareinventinghundredsofmoleculesthathaveneverexistedbefore.So,yes,weareinventing,"hesays."Weareinventingtosolveproblems."CarolineFox,M.D.ispassionateaboutgenetics.Inmedicalschool,shestudiedtheeffectsoftheenvironmentondiabetesandobesityonatribeofNativeAmericans(certainpopulationsworldwidehaveagreaterpropensitytowardsdiabetes;thistribewasonesuchgroup).Herresearchlefthermotivatedtolearnmoreabouthowgeneticsplaysaroleinmetabolicdiseases.Thatwasmystart,shenotes.Sincethen,almostallofmyresearchhasbeenfocusedonuncoveringthegeneticfoundationsofthesetypesofdiseases.ChangingPerceptionsPriortojoiningMSDResearchLaboratoriesinBoston,CarolineworkedattheNationalInstitutesofHealth.There,sheledalabthatstudiedmetabolicriskfactorsforcardiovasculardiseaseaspartofthe,apioneeringlong-termpopulationstudyofcardiovasculardisease.But,shenotes,theshifttoMSDwasarelativelyeasyone.IwasimpressedbyMSDseffortstoleveragehumangeneticstodrivedrugdiscovery,shesays.Forme,itwastheperfectnextstepfromtheworkthatIhadbeendoinginacademia.Genetics:TheNewFrontierWe'relucky—CarolinespassionforgeneticsisagreatfitforMSD.Inourlabsandacrosstheindustry,weareseeinganincreaseduseofhumangeneticstohelpdeterminewhetherpatientswillrespondtoacertaindrugornot,ShepointstoMSD'sactiveresearchcollaborationswithscientistsaroundtheworldaimedatadvancingthisfieldofscience.Iamveryenthusiasticaboutwhereourresearchmaylead.Ourcompanyiscommittedtodiscoveringsmart,sustainablewaystoexpandaccesstohealthcare,especiallyinareaswithlimitedinfrastructureandresources.Giventhesignificanceofthischallenge,itisonlybyworkinginpartnershipwithothers—governments,donors,patientorganizations,healthcareprofessionals,NGOs,academicinstitutions,multilateralorganizationsandtheprivatesector—thatwecanwemakethestrongestcontribution.TheMSDFellowshipforGlobalHealthisbuiltonthenotionofpartneringtostrengthenthecapacityandreachofnonprofitorganizationswhich,inturn,willultimatelysolvesomeoftheworld’sgreatesthealthcarechallenges.

  Dr.Chenghasbeentreatingheadandneckcancerpatientsformanyyears.Thisishispersonalperspective.Ihavetreatedpatientswithheadandneckcancersformanyyears,soIhaveseen,upclose,thedifficultexperienceoflivingwithheadandneckcancer.Cancerisatryingsituationforallpatientsandtheirlovedones,butheadandneckpatientsfacecancerinauniqueanddifficultway,withtheirdiseaseandtumorsoftenvisibletothepublic.Ihavebeeninvolvedinresearchforyearsaspartofscientists'decades-longendeavortobringforwardmeaningfuladvancesforpatientsdiagnosedwiththispotentiallyaggressivedisease.Untilrecently,suchadvanceswerehardtocomebyandmypatientsandIstruggledwiththelimitedtreatmentoptionsavailable.Butwhilethereisasignificantneedfornewtreatmentoptions,thegoodnewsisthattherehavebeensomeimprovementsinsurvivalratesovertheyearsandweareseeinganewandencouragingfutureahead.Wehavebeguntoleverageourunderstandingofbiologytodevelopmoreprecisetherapies.AtMSD,wearefocusedonimmuno-oncologyresearch,whichstudiestheroleoftheimmunesystemindetectingandfightingcancer.Wearestudyingthepotentialofthisapproach,whichaimstoharnessandrestorethebodysabilitytodetectandfightcancercells,inanumberofcancers,includingheadandneckcancer.Immuno-oncologyhasalreadysignificantlychangedthewaycertaincancersaretreated,includingmelanomaandlungcancer,aswellasinthetreatmentofheadandneckcancer.Changeiscomingtotheheadandneckcancerlandscape–anditisthrillingtobeapartofit.TobeabletoseehowourresearchandeffortsatMSDarehavingadirectimpactonhowphysiciansapproachthetreatmentoftheirpatientsandwhatpatientsmayexpectfromtheirtreatmentiswhatmotivatesustoworkharder.Jameslikeslogicpuzzles.Andwordproblems.Luckily,hegetstoapplytheseinterestsinhisworkeveryday.Jamesisacomputationalchemist–heworkswithMSD’schemistryteams,applyingpredictivemodellingtoidentifywaystodesigndrugsandanalyzedatatohelpourscientistsprioritizethenextcompoundstomakeandtest.Althoughthesearecomplexproblemsandcomplexquestionsthatwe’retryingtosolve,wetakelogicalsteps,explainsJames.Foreveryquestion,there’sreallyananswer,yousometimesjusthavetospendalittlebitmoretimethinkingaboutit,andtakeastepbackandlookatwhat’sactuallyinfrontofyou.Bettermolecules,fasterInourgroup’sroleindrugdiscovery,wehavethismantraof‘bettermolecules,faster,saysJames.Ifachemisthas100compoundsthatshe’sthinkingaboutmaking,computationally,wecanhelpprioritizewhichonestostartwithbasedonrationaldrugdesign.Jamesenjoysbeingpartofateamworkingtoachieveasingulargoal:tocreatemedicinesthatwillhelpthepeoplewhoneedthem.And,hebelievesthatcollaborationisveryimportantforresearchanddevelopment:Youcan'tdoaprojectonyourown;youneedotherstoassistandhelp,notjustbycontributingintheirindividualrole,butalsowiththeirthinking.Jamesandhiscolleagueshavealotofexperiencewithperseveranceanddetermination,too.Ourteamsofscientistsdesign,developandscreenthousandsofcompoundsandantibodiestoultimatelyadvanceonlyafewofthemostpromisingleadcandidatesintoclinicaltesting.Moleculardesignanddevelopmentisaniterativeprocess.Youhavetostickwithit.It'scontinuouslymakingmodificationsandadaptingandevolving,eventuallygettingdowntheroadorthepipelinetomakeadrug…that'swhat'sexcitingaboutit.It’sallaboutthepatientsEveryday,IcometoworkknowingthatI’mworkingtomakeadrug.And,Idon'tknowiftodayI’mgoingtoopenupanemailwithresultssaying,‘we'veaccomplishedthisor‘weneedtochangethat.’Butregardlessofwhatthoseresultsare,it'sgoingtobeprogresstogettothatendpoint.”Ourcompanyiscommittedtodiscoveringsmart,sustainablewaystoexpandaccesstohealthcare,especiallyinareaswithlimitedinfrastructureandresources.Giventhesignificanceofthischallenge,itisonlybyworkinginpartnershipwithothers—governments,donors,patientorganizations,healthcareprofessionals,NGOs,academicinstitutions,multilateralorganizationsandtheprivatesector—thatwecanwemakethestrongestcontribution.TheMSDFellowshipforGlobalHealthisbuiltonthenotionofpartneringtostrengthenthecapacityandreachofnonprofitorganizationswhich,inturn,willultimatelysolvesomeoftheworld’sgreatesthealthcarechallenges.

  Dr.Chenghasbeentreatingheadandneckcancerpatientsformanyyears.Thisishispersonalperspective.Ihavetreatedpatientswithheadandneckcancersformanyyears,soIhaveseen,upclose,thedifficultexperienceoflivingwithheadandneckcancer.Cancerisatryingsituationforallpatientsandtheirlovedones,butheadandneckpatientsfacecancerinauniqueanddifficultway,withtheirdiseaseandtumorsoftenvisibletothepublic.Ihavebeeninvolvedinresearchforyearsaspartofscientists'decades-longendeavortobringforwardmeaningfuladvancesforpatientsdiagnosedwiththispotentiallyaggressivedisease.Untilrecently,suchadvanceswerehardtocomebyandmypatientsandIstruggledwiththelimitedtreatmentoptionsavailable.Butwhilethereisasignificantneedfornewtreatmentoptions,thegoodnewsisthattherehavebeensomeimprovementsinsurvivalratesovertheyearsandweareseeinganewandencouragingfutureahead.Wehavebeguntoleverageourunderstandingofbiologytodevelopmoreprecisetherapies.AtMSD,wearefocusedonimmuno-oncologyresearch,whichstudiestheroleoftheimmunesystemindetectingandfightingcancer.Wearestudyingthepotentialofthisapproach,whichaimstoharnessandrestorethebodysabilitytodetectandfightcancercells,inanumberofcancers,includingheadandneckcancer.Immuno-oncologyhasalreadysignificantlychangedthewaycertaincancersaretreated,includingmelanomaandlungcancer,aswellasinthetreatmentofheadandneckcancer.Changeiscomingtotheheadandneckcancerlandscape–anditisthrillingtobeapartofit.TobeabletoseehowourresearchandeffortsatMSDarehavingadirectimpactonhowphysiciansapproachthetreatmentoftheirpatientsandwhatpatientsmayexpectfromtheirtreatmentiswhatmotivatesustoworkharder.Dr.Chenghasbeentreatingheadandneckcancerpatientsformanyyears.Thisishispersonalperspective.Ihavetreatedpatientswithheadandneckcancersformanyyears,soIhaveseen,upclose,thedifficultexperienceoflivingwithheadandneckcancer.Cancerisatryingsituationforallpatientsandtheirlovedones,butheadandneckpatientsfacecancerinauniqueanddifficultway,withtheirdiseaseandtumorsoftenvisibletothepublic.Ihavebeeninvolvedinresearchforyearsaspartofscientists'decades-longendeavortobringforwardmeaningfuladvancesforpatientsdiagnosedwiththispotentiallyaggressivedisease.Untilrecently,suchadvanceswerehardtocomebyandmypatientsandIstruggledwiththelimitedtreatmentoptionsavailable.Butwhilethereisasignificantneedfornewtreatmentoptions,thegoodnewsisthattherehavebeensomeimprovementsinsurvivalratesovertheyearsandweareseeinganewandencouragingfutureahead.Wehavebeguntoleverageourunderstandingofbiologytodevelopmoreprecisetherapies.AtMSD,wearefocusedonimmuno-oncologyresearch,whichstudiestheroleoftheimmunesystemindetectingandfightingcancer.Wearestudyingthepotentialofthisapproach,whichaimstoharnessandrestorethebodysabilitytodetectandfightcancercells,inanumberofcancers,includingheadandneckcancer.Immuno-oncologyhasalreadysignificantlychangedthewaycertaincancersaretreated,includingmelanomaandlungcancer,aswellasinthetreatmentofheadandneckcancer.Changeiscomingtotheheadandneckcancerlandscape–anditisthrillingtobeapartofit.TobeabletoseehowourresearchandeffortsatMSDarehavingadirectimpactonhowphysiciansapproachthetreatmentoftheirpatientsandwhatpatientsmayexpectfromtheirtreatmentiswhatmotivatesustoworkharder.Ourcompanyiscommittedtodiscoveringsmart,sustainablewaystoexpandaccesstohealthcare,especiallyinareaswithlimitedinfrastructureandresources.Giventhesignificanceofthischallenge,itisonlybyworkinginpartnershipwithothers—governments,donors,patientorganizations,healthcareprofessionals,NGOs,academicinstitutions,multilateralorganizationsandtheprivatesector—thatwecanwemakethestrongestcontribution.TheMSDFellowshipforGlobalHealthisbuiltonthenotionofpartneringtostrengthenthecapacityandreachofnonprofitorganizationswhich,inturn,willultimatelysolvesomeoftheworld’sgreatesthealthcarechallenges.

  CarolineFox,M.D.ispassionateaboutgenetics.Inmedicalschool,shestudiedtheeffectsoftheenvironmentondiabetesandobesityonatribeofNativeAmericans(certainpopulationsworldwidehaveagreaterpropensitytowardsdiabetes;thistribewasonesuchgroup).Herresearchlefthermotivatedtolearnmoreabouthowgeneticsplaysaroleinmetabolicdiseases.Thatwasmystart,shenotes.Sincethen,almostallofmyresearchhasbeenfocusedonuncoveringthegeneticfoundationsofthesetypesofdiseases.ChangingPerceptionsPriortojoiningMSDResearchLaboratoriesinBoston,CarolineworkedattheNationalInstitutesofHealth.There,sheledalabthatstudiedmetabolicriskfactorsforcardiovasculardiseaseaspartofthe,apioneeringlong-termpopulationstudyofcardiovasculardisease.But,shenotes,theshifttoMSDwasarelativelyeasyone.IwasimpressedbyMSDseffortstoleveragehumangeneticstodrivedrugdiscovery,shesays.Forme,itwastheperfectnextstepfromtheworkthatIhadbeendoinginacademia.Genetics:TheNewFrontierWe'relucky—CarolinespassionforgeneticsisagreatfitforMSD.Inourlabsandacrosstheindustry,weareseeinganincreaseduseofhumangeneticstohelpdeterminewhetherpatientswillrespondtoacertaindrugornot,ShepointstoMSD'sactiveresearchcollaborationswithscientistsaroundtheworldaimedatadvancingthisfieldofscience.Iamveryenthusiasticaboutwhereourresearchmaylead.Toexpressourappreciation,MSDbegan#DearCancerHeroes–asocialmediacampaigntorecognizetheirfortitudeandcontributionstothefield.It’sasmallgesturetoshowourgratitude.Wewanttoletclinicaltrialparticipantsknowtheyarenotaloneandthereisawholecommunityofpeoplecheeringthemon.Anyonecanjointhemovementbywritingamessagetocancerclinicaltrialparticipantsonastickynoteandsharingitonsocialmediausing#DearCancerHeroes.Cancerresearchhascomealongwayandstillhasalongwaytogo.However,wewouldn’thavegottentowherewearetodaywithouttheseheroes.Toexpressourappreciation,MSDbegan#DearCancerHeroes–asocialmediacampaigntorecognizetheirfortitudeandcontributionstothefield.It’sasmallgesturetoshowourgratitude.Wewanttoletclinicaltrialparticipantsknowtheyarenotaloneandthereisawholecommunityofpeoplecheeringthemon.Anyonecanjointhemovementbywritingamessagetocancerclinicaltrialparticipantsonastickynoteandsharingitonsocialmediausing#DearCancerHeroes.Cancerresearchhascomealongwayandstillhasalongwaytogo.However,wewouldn’thavegottentowherewearetodaywithouttheseheroes.

  Toexpressourappreciation,MSDbegan#DearCancerHeroes–asocialmediacampaigntorecognizetheirfortitudeandcontributionstothefield.It’sasmallgesturetoshowourgratitude.Wewanttoletclinicaltrialparticipantsknowtheyarenotaloneandthereisawholecommunityofpeoplecheeringthemon.Anyonecanjointhemovementbywritingamessagetocancerclinicaltrialparticipantsonastickynoteandsharingitonsocialmediausing#DearCancerHeroes.Cancerresearchhascomealongwayandstillhasalongwaytogo.However,wewouldn’thavegottentowherewearetodaywithouttheseheroes.Toexpressourappreciation,MSDbegan#DearCancerHeroes–asocialmediacampaigntorecognizetheirfortitudeandcontributionstothefield.It’sasmallgesturetoshowourgratitude.Wewanttoletclinicaltrialparticipantsknowtheyarenotaloneandthereisawholecommunityofpeoplecheeringthemon.Anyonecanjointhemovementbywritingamessagetocancerclinicaltrialparticipantsonastickynoteandsharingitonsocialmediausing#DearCancerHeroes.Cancerresearchhascomealongwayandstillhasalongwaytogo.However,wewouldn’thavegottentowherewearetodaywithouttheseheroes.CarolineFox,M.D.ispassionateaboutgenetics.Inmedicalschool,shestudiedtheeffectsoftheenvironmentondiabetesandobesityonatribeofNativeAmericans(certainpopulationsworldwidehaveagreaterpropensitytowardsdiabetes;thistribewasonesuchgroup).Herresearchlefthermotivatedtolearnmoreabouthowgeneticsplaysaroleinmetabolicdiseases.Thatwasmystart,shenotes.Sincethen,almostallofmyresearchhasbeenfocusedonuncoveringthegeneticfoundationsofthesetypesofdiseases.ChangingPerceptionsPriortojoiningMSDResearchLaboratoriesinBoston,CarolineworkedattheNationalInstitutesofHealth.There,sheledalabthatstudiedmetabolicriskfactorsforcardiovasculardiseaseaspartofthe,apioneeringlong-termpopulationstudyofcardiovasculardisease.But,shenotes,theshifttoMSDwasarelativelyeasyone.IwasimpressedbyMSDseffortstoleveragehumangeneticstodrivedrugdiscovery,shesays.Forme,itwastheperfectnextstepfromtheworkthatIhadbeendoinginacademia.Genetics:TheNewFrontierWe'relucky—CarolinespassionforgeneticsisagreatfitforMSD.Inourlabsandacrosstheindustry,weareseeinganincreaseduseofhumangeneticstohelpdeterminewhetherpatientswillrespondtoacertaindrugornot,ShepointstoMSD'sactiveresearchcollaborationswithscientistsaroundtheworldaimedatadvancingthisfieldofscience.Iamveryenthusiasticaboutwhereourresearchmaylead.

  Jameslikeslogicpuzzles.Andwordproblems.Luckily,hegetstoapplytheseinterestsinhisworkeveryday.Jamesisacomputationalchemist–heworkswithMSD’schemistryteams,applyingpredictivemodellingtoidentifywaystodesigndrugsandanalyzedatatohelpourscientistsprioritizethenextcompoundstomakeandtest.Althoughthesearecomplexproblemsandcomplexquestionsthatwe’retryingtosolve,wetakelogicalsteps,explainsJames.Foreveryquestion,there’sreallyananswer,yousometimesjusthavetospendalittlebitmoretimethinkingaboutit,andtakeastepbackandlookatwhat’sactuallyinfrontofyou.Bettermolecules,fasterInourgroup’sroleindrugdiscovery,wehavethismantraof‘bettermolecules,faster,saysJames.Ifachemisthas100compoundsthatshe’sthinkingaboutmaking,computationally,wecanhelpprioritizewhichonestostartwithbasedonrationaldrugdesign.Jamesenjoysbeingpartofateamworkingtoachieveasingulargoal:tocreatemedicinesthatwillhelpthepeoplewhoneedthem.And,hebelievesthatcollaborationisveryimportantforresearchanddevelopment:Youcan'tdoaprojectonyourown;youneedotherstoassistandhelp,notjustbycontributingintheirindividualrole,butalsowiththeirthinking.Jamesandhiscolleagueshavealotofexperiencewithperseveranceanddetermination,too.Ourteamsofscientistsdesign,developandscreenthousandsofcompoundsandantibodiestoultimatelyadvanceonlyafewofthemostpromisingleadcandidatesintoclinicaltesting.Moleculardesignanddevelopmentisaniterativeprocess.Youhavetostickwithit.It'scontinuouslymakingmodificationsandadaptingandevolving,eventuallygettingdowntheroadorthepipelinetomakeadrug…that'swhat'sexcitingaboutit.It’sallaboutthepatientsEveryday,IcometoworkknowingthatI’mworkingtomakeadrug.And,Idon'tknowiftodayI’mgoingtoopenupanemailwithresultssaying,‘we'veaccomplishedthisor‘weneedtochangethat.’Butregardlessofwhatthoseresultsare,it'sgoingtobeprogresstogettothatendpoint.”“MyuncleIvanwasaseverediabetespatient—heneededinjectionsthreetimesaday.Hewaswithoutinsulinformorethanamonth.EvenIwasnotaware,”Pablorecounts.“Whenhefinallyreceivedinsulin,hewasinbadcondition.Severalweekslater,hishealthdeclined,hehadrenalfailure,andhedied.”ThedroneteamrecentlyacknowledgedPablo’scontributions,andhispersonalloss,bygivingtheprojectanewnickname.Oncecalled“MajorTom”aftertheDavidBowiesong,it’snow“ProjectIvan.”“Idon’thavewordsenoughtoshowmygratitude,”Pablosays.“Thisisaboutsavinglives.”In1962hercollaborators,JamesWatson,FrancisCrickandMauriceWilkinswereawardedtheNobelPrizefortheir“discoveriesconcerningthemolecularstructureofnucleicacidsanditssignificanceforinformationtransferinlivingmaterial.”Franklin’suntimelydeathdeniedhertheacclaimofthisprestigiousscientificaward(theNobelCommitteedoesnotawardtheprizeposthumously),butherroleinthisfundamentaldiscoveryhasbeenwelldocumentedandisnowwidelyrecognized.Franklin’sstoryofalifecutshortbyovariancancerremainsalltoocommon.Eventoday,advancedovariancancerremainsoneofthemostdifficultcancerstotreat.Butthereremainsareasonforoptimism.Thepaceofchangeincancertreatmenthasincreaseddramaticallyinrecentyears.Advancesinresearch–manyofwhichmaybetracedbacktoFranklin’swork–havegivenusadeeperunderstandingofhowtotargetthedisease,pavingthewayfornewdevelopments.Specifictoovariancancer,recentclinicalresearchhasshownpromiseforwomenwithadvancedstagesofthedisease.AtMSD,wearefocusedontranslatingbreakthroughscienceintooncologytherapeuticsthathavethegreatestpotentialforimprovinglong-termdiseasecontrolandsurvivalforpatients,includingthosewithovariancancer.Werecognizethatnotwopatientsorcancersarethesameandmultipleapproaches–therapeuticregimensandmechanismsofaction–willbeneededtooutpacethisdisease.That’swhywehaveworkedrigorouslytoexpandanddiversifyourowninternalresearchprograms.Thereisstillworktobedone,butwebelievestronglyinourpotentialtotransformthewayallcancersaretreated.AndweareconstantlyinspiredtoworkharderbystorieslikeRosalindFranklin’s.

  CarolineFox,M.D.ispassionateaboutgenetics.Inmedicalschool,shestudiedtheeffectsoftheenvironmentondiabetesandobesityonatribeofNativeAmericans(certainpopulationsworldwidehaveagreaterpropensitytowardsdiabetes;thistribewasonesuchgroup).Herresearchlefthermotivatedtolearnmoreabouthowgeneticsplaysaroleinmetabolicdiseases.Thatwasmystart,shenotes.Sincethen,almostallofmyresearchhasbeenfocusedonuncoveringthegeneticfoundationsofthesetypesofdiseases.ChangingPerceptionsPriortojoiningMSDResearchLaboratoriesinBoston,CarolineworkedattheNationalInstitutesofHealth.There,sheledalabthatstudiedmetabolicriskfactorsforcardiovasculardiseaseaspartofthe,apioneeringlong-termpopulationstudyofcardiovasculardisease.But,shenotes,theshifttoMSDwasarelativelyeasyone.IwasimpressedbyMSDseffortstoleveragehumangeneticstodrivedrugdiscovery,shesays.Forme,itwastheperfectnextstepfromtheworkthatIhadbeendoinginacademia.Genetics:TheNewFrontierWe'relucky—CarolinespassionforgeneticsisagreatfitforMSD.Inourlabsandacrosstheindustry,weareseeinganincreaseduseofhumangeneticstohelpdeterminewhetherpatientswillrespondtoacertaindrugornot,ShepointstoMSD'sactiveresearchcollaborationswithscientistsaroundtheworldaimedatadvancingthisfieldofscience.Iamveryenthusiasticaboutwhereourresearchmaylead.Chemistryhasbeencentraltoourbusinessofsinceourearliestdaysasacompany.Historically,ourdrugdiscoveryprocessprimarilycenteredaroundsmallmolecules.Then,thebirthofbiotechnologyinthelate1970s/early1980saddedbiologics,orengineeredproteins,tothemix.Today,newmodalitiesareemergingthatshowastrongpotentialtotargetcomplexdiseasesthathavenotyetbeenreachablewitheithersmallmoleculesorbiologics.RobGarbaccioisleadingatalentedteamofchemistswhoarehelpingguideMSD’sentryintothisexcitingnewfieldofmedicine.IntroducinganddiscoveringnewwaysforwardRobistheassociatevicepresident,ChemistryCapabilitiesforAcceleratingTherapeutics(CCAT),adiscoverychemistryteamthatislookingathowtogobeyondthetraditionalmethodsofdiscoveringanddevelopingmedicines."Therearecertaindiseasetargetsthatarereallyhardto'reach'andimpactusingtraditionalmethods,"henotes."SopartofthegroupIoverseetriestofigureouthowwecanemploynewermodalities,suchaspeptides,bioconjugates,andoligonucleotides,toaddressthechallengingtargetsthatareincreasinglyemergingfrombiologicalresearch."Rob'sgroupisnotfocusedonanyspecifictherapeuticarea--theyareseekingnewwaystoaddressthemostdifficultdiseasetargets."Inoncology,infectiousdiseases,andneuroscience,forexample,we’relookingforthosetargetsthatourcolleaguessay,'Ifonlywecouldmodulatethistarget,webelievewemightbeabletopotentiallyinterruptthediseaseprocessandhelppatients,'"henotes.Using‘creativechemistry’totreatdiseaseIt'scomplexwork,tobesure,butthat'swhatmakesitsointriguingandinspiringforRobandhisteam."ThethingthatIlikethemostaboutmyworkisthebeliefthattheremaybeapathforwardforthetreatmentofeachandeveryoneofthesediseases.Wejustcan'tseeityetbecausethebiologyissocomplex,"saysRob."Asresearcherscontinuetoimproveourunderstandingofdiseasebiology,Ibelievethatcombiningthatknowledgewithcreativechemistrywillhelpleadusdownnewroadstotreatingdiseaseandhelpingpatients."Robjoinedthecompanyaftercompletinggraduateschoolandapostdoctoralfellowshipfocusingonorganicchemistry."Icameherebecausescienceandinnovationdrivethiscompany.I'mpassionateaboutourmissiontosaveandimprovelives,andIbelievethatmybestdayatwork,thedaymyteammakesapotentiallylife-changingdiscovery,isstillaheadofme,andit'sthereasonthatIstay."InventingforlifeAtMSD,wesayweare.AndRobdefinitelyseeshimselfasaninventor."Chemistshavethisuniqueabilitytocombineatomsandbondsbetweenatomsinauniqueway.Everydaychemistsareinventinghundredsofmoleculesthathaveneverexistedbefore.So,yes,weareinventing,"hesays."Weareinventingtosolveproblems."In1962hercollaborators,JamesWatson,FrancisCrickandMauriceWilkinswereawardedtheNobelPrizefortheir“discoveriesconcerningthemolecularstructureofnucleicacidsanditssignificanceforinformationtransferinlivingmaterial.”Franklin’suntimelydeathdeniedhertheacclaimofthisprestigiousscientificaward(theNobelCommitteedoesnotawardtheprizeposthumously),butherroleinthisfundamentaldiscoveryhasbeenwelldocumentedandisnowwidelyrecognized.Franklin’sstoryofalifecutshortbyovariancancerremainsalltoocommon.Eventoday,advancedovariancancerremainsoneofthemostdifficultcancerstotreat.Butthereremainsareasonforoptimism.Thepaceofchangeincancertreatmenthasincreaseddramaticallyinrecentyears.Advancesinresearch–manyofwhichmaybetracedbacktoFranklin’swork–havegivenusadeeperunderstandingofhowtotargetthedisease,pavingthewayfornewdevelopments.Specifictoovariancancer,recentclinicalresearchhasshownpromiseforwomenwithadvancedstagesofthedisease.AtMSD,wearefocusedontranslatingbreakthroughscienceintooncologytherapeuticsthathavethegreatestpotentialforimprovinglong-termdiseasecontrolandsurvivalforpatients,includingthosewithovariancancer.Werecognizethatnotwopatientsorcancersarethesameandmultipleapproaches–therapeuticregimensandmechanismsofaction–willbeneededtooutpacethisdisease.That’swhywehaveworkedrigorouslytoexpandanddiversifyourowninternalresearchprograms.Thereisstillworktobedone,butwebelievestronglyinourpotentialtotransformthewayallcancersaretreated.AndweareconstantlyinspiredtoworkharderbystorieslikeRosalindFranklin’s.

  CarolineFox,M.D.ispassionateaboutgenetics.Inmedicalschool,shestudiedtheeffectsoftheenvironmentondiabetesandobesityonatribeofNativeAmericans(certainpopulationsworldwidehaveagreaterpropensitytowardsdiabetes;thistribewasonesuchgroup).Herresearchlefthermotivatedtolearnmoreabouthowgeneticsplaysaroleinmetabolicdiseases.Thatwasmystart,shenotes.Sincethen,almostallofmyresearchhasbeenfocusedonuncoveringthegeneticfoundationsofthesetypesofdiseases.ChangingPerceptionsPriortojoiningMSDResearchLaboratoriesinBoston,CarolineworkedattheNationalInstitutesofHealth.There,sheledalabthatstudiedmetabolicriskfactorsforcardiovasculardiseaseaspartofthe,apioneeringlong-termpopulationstudyofcardiovasculardisease.But,shenotes,theshifttoMSDwasarelativelyeasyone.IwasimpressedbyMSDseffortstoleveragehumangeneticstodrivedrugdiscovery,shesays.Forme,itwastheperfectnextstepfromtheworkthatIhadbeendoinginacademia.Genetics:TheNewFrontierWe'relucky—CarolinespassionforgeneticsisagreatfitforMSD.Inourlabsandacrosstheindustry,weareseeinganincreaseduseofhumangeneticstohelpdeterminewhetherpatientswillrespondtoacertaindrugornot,ShepointstoMSD'sactiveresearchcollaborationswithscientistsaroundtheworldaimedatadvancingthisfieldofscience.Iamveryenthusiasticaboutwhereourresearchmaylead.Jameslikeslogicpuzzles.Andwordproblems.Luckily,hegetstoapplytheseinterestsinhisworkeveryday.Jamesisacomputationalchemist–heworkswithMSD’schemistryteams,applyingpredictivemodellingtoidentifywaystodesigndrugsandanalyzedatatohelpourscientistsprioritizethenextcompoundstomakeandtest.Althoughthesearecomplexproblemsandcomplexquestionsthatwe’retryingtosolve,wetakelogicalsteps,explainsJames.Foreveryquestion,there’sreallyananswer,yousometimesjusthavetospendalittlebitmoretimethinkingaboutit,andtakeastepbackandlookatwhat’sactuallyinfrontofyou.Bettermolecules,fasterInourgroup’sroleindrugdiscovery,wehavethismantraof‘bettermolecules,faster,saysJames.Ifachemisthas100compoundsthatshe’sthinkingaboutmaking,computationally,wecanhelpprioritizewhichonestostartwithbasedonrationaldrugdesign.Jamesenjoysbeingpartofateamworkingtoachieveasingulargoal:tocreatemedicinesthatwillhelpthepeoplewhoneedthem.And,hebelievesthatcollaborationisveryimportantforresearchanddevelopment:Youcan'tdoaprojectonyourown;youneedotherstoassistandhelp,notjustbycontributingintheirindividualrole,butalsowiththeirthinking.Jamesandhiscolleagueshavealotofexperiencewithperseveranceanddetermination,too.Ourteamsofscientistsdesign,developandscreenthousandsofcompoundsandantibodiestoultimatelyadvanceonlyafewofthemostpromisingleadcandidatesintoclinicaltesting.Moleculardesignanddevelopmentisaniterativeprocess.Youhavetostickwithit.It'scontinuouslymakingmodificationsandadaptingandevolving,eventuallygettingdowntheroadorthepipelinetomakeadrug…that'swhat'sexcitingaboutit.It’sallaboutthepatientsEveryday,IcometoworkknowingthatI’mworkingtomakeadrug.And,Idon'tknowiftodayI’mgoingtoopenupanemailwithresultssaying,‘we'veaccomplishedthisor‘weneedtochangethat.’Butregardlessofwhatthoseresultsare,it'sgoingtobeprogresstogettothatendpoint.”In1962hercollaborators,JamesWatson,FrancisCrickandMauriceWilkinswereawardedtheNobelPrizefortheir“discoveriesconcerningthemolecularstructureofnucleicacidsanditssignificanceforinformationtransferinlivingmaterial.”Franklin’suntimelydeathdeniedhertheacclaimofthisprestigiousscientificaward(theNobelCommitteedoesnotawardtheprizeposthumously),butherroleinthisfundamentaldiscoveryhasbeenwelldocumentedandisnowwidelyrecognized.Franklin’sstoryofalifecutshortbyovariancancerremainsalltoocommon.Eventoday,advancedovariancancerremainsoneofthemostdifficultcancerstotreat.Butthereremainsareasonforoptimism.Thepaceofchangeincancertreatmenthasincreaseddramaticallyinrecentyears.Advancesinresearch–manyofwhichmaybetracedbacktoFranklin’swork–havegivenusadeeperunderstandingofhowtotargetthedisease,pavingthewayfornewdevelopments.Specifictoovariancancer,recentclinicalresearchhasshownpromiseforwomenwithadvancedstagesofthedisease.AtMSD,wearefocusedontranslatingbreakthroughscienceintooncologytherapeuticsthathavethegreatestpotentialforimprovinglong-termdiseasecontrolandsurvivalforpatients,includingthosewithovariancancer.Werecognizethatnotwopatientsorcancersarethesameandmultipleapproaches–therapeuticregimensandmechanismsofaction–willbeneededtooutpacethisdisease.That’swhywehaveworkedrigorouslytoexpandanddiversifyourowninternalresearchprograms.Thereisstillworktobedone,butwebelievestronglyinourpotentialtotransformthewayallcancersaretreated.AndweareconstantlyinspiredtoworkharderbystorieslikeRosalindFranklin’s.

  “MyuncleIvanwasaseverediabetespatient—heneededinjectionsthreetimesaday.Hewaswithoutinsulinformorethanamonth.EvenIwasnotaware,”Pablorecounts.“Whenhefinallyreceivedinsulin,hewasinbadcondition.Severalweekslater,hishealthdeclined,hehadrenalfailure,andhedied.”ThedroneteamrecentlyacknowledgedPablo’scontributions,andhispersonalloss,bygivingtheprojectanewnickname.Oncecalled“MajorTom”aftertheDavidBowiesong,it’snow“ProjectIvan.”“Idon’thavewordsenoughtoshowmygratitude,”Pablosays.“Thisisaboutsavinglives.”Ourcompanyiscommittedtodiscoveringsmart,sustainablewaystoexpandaccesstohealthcare,especiallyinareaswithlimitedinfrastructureandresources.Giventhesignificanceofthischallenge,itisonlybyworkinginpartnershipwithothers—governments,donors,patientorganizations,healthcareprofessionals,NGOs,academicinstitutions,multilateralorganizationsandtheprivatesector—thatwecanwemakethestrongestcontribution.TheMSDFellowshipforGlobalHealthisbuiltonthenotionofpartneringtostrengthenthecapacityandreachofnonprofitorganizationswhich,inturn,willultimatelysolvesomeoftheworld’sgreatesthealthcarechallenges.Chemistryhasbeencentraltoourbusinessofsinceourearliestdaysasacompany.Historically,ourdrugdiscoveryprocessprimarilycenteredaroundsmallmolecules.Then,thebirthofbiotechnologyinthelate1970s/early1980saddedbiologics,orengineeredproteins,tothemix.Today,newmodalitiesareemergingthatshowastrongpotentialtotargetcomplexdiseasesthathavenotyetbeenreachablewitheithersmallmoleculesorbiologics.RobGarbaccioisleadingatalentedteamofchemistswhoarehelpingguideMSD’sentryintothisexcitingnewfieldofmedicine.IntroducinganddiscoveringnewwaysforwardRobistheassociatevicepresident,ChemistryCapabilitiesforAcceleratingTherapeutics(CCAT),adiscoverychemistryteamthatislookingathowtogobeyondthetraditionalmethodsofdiscoveringanddevelopingmedicines."Therearecertaindiseasetargetsthatarereallyhardto'reach'andimpactusingtraditionalmethods,"henotes."SopartofthegroupIoverseetriestofigureouthowwecanemploynewermodalities,suchaspeptides,bioconjugates,andoligonucleotides,toaddressthechallengingtargetsthatareincreasinglyemergingfrombiologicalresearch."Rob'sgroupisnotfocusedonanyspecifictherapeuticarea--theyareseekingnewwaystoaddressthemostdifficultdiseasetargets."Inoncology,infectiousdiseases,andneuroscience,forexample,we’relookingforthosetargetsthatourcolleaguessay,'Ifonlywecouldmodulatethistarget,webelievewemightbeabletopotentiallyinterruptthediseaseprocessandhelppatients,'"henotes.Using‘creativechemistry’totreatdiseaseIt'scomplexwork,tobesure,butthat'swhatmakesitsointriguingandinspiringforRobandhisteam."ThethingthatIlikethemostaboutmyworkisthebeliefthattheremaybeapathforwardforthetreatmentofeachandeveryoneofthesediseases.Wejustcan'tseeityetbecausethebiologyissocomplex,"saysRob."Asresearcherscontinuetoimproveourunderstandingofdiseasebiology,Ibelievethatcombiningthatknowledgewithcreativechemistrywillhelpleadusdownnewroadstotreatingdiseaseandhelpingpatients."Robjoinedthecompanyaftercompletinggraduateschoolandapostdoctoralfellowshipfocusingonorganicchemistry."Icameherebecausescienceandinnovationdrivethiscompany.I'mpassionateaboutourmissiontosaveandimprovelives,andIbelievethatmybestdayatwork,thedaymyteammakesapotentiallylife-changingdiscovery,isstillaheadofme,andit'sthereasonthatIstay."InventingforlifeAtMSD,wesayweare.AndRobdefinitelyseeshimselfasaninventor."Chemistshavethisuniqueabilitytocombineatomsandbondsbetweenatomsinauniqueway.Everydaychemistsareinventinghundredsofmoleculesthathaveneverexistedbefore.So,yes,weareinventing,"hesays."Weareinventingtosolveproblems."

  In1962hercollaborators,JamesWatson,FrancisCrickandMauriceWilkinswereawardedtheNobelPrizefortheir“discoveriesconcerningthemolecularstructureofnucleicacidsanditssignificanceforinformationtransferinlivingmaterial.”Franklin’suntimelydeathdeniedhertheacclaimofthisprestigiousscientificaward(theNobelCommitteedoesnotawardtheprizeposthumously),butherroleinthisfundamentaldiscoveryhasbeenwelldocumentedandisnowwidelyrecognized.Franklin’sstoryofalifecutshortbyovariancancerremainsalltoocommon.Eventoday,advancedovariancancerremainsoneofthemostdifficultcancerstotreat.Butthereremainsareasonforoptimism.Thepaceofchangeincancertreatmenthasincreaseddramaticallyinrecentyears.Advancesinresearch–manyofwhichmaybetracedbacktoFranklin’swork–havegivenusadeeperunderstandingofhowtotargetthedisease,pavingthewayfornewdevelopments.Specifictoovariancancer,recentclinicalresearchhasshownpromiseforwomenwithadvancedstagesofthedisease.AtMSD,wearefocusedontranslatingbreakthroughscienceintooncologytherapeuticsthathavethegreatestpotentialforimprovinglong-termdiseasecontrolandsurvivalforpatients,includingthosewithovariancancer.Werecognizethatnotwopatientsorcancersarethesameandmultipleapproaches–therapeuticregimensandmechanismsofaction–willbeneededtooutpacethisdisease.That’swhywehaveworkedrigorouslytoexpandanddiversifyourowninternalresearchprograms.Thereisstillworktobedone,butwebelievestronglyinourpotentialtotransformthewayallcancersaretreated.AndweareconstantlyinspiredtoworkharderbystorieslikeRosalindFranklin’s.Dr.Chenghasbeentreatingheadandneckcancerpatientsformanyyears.Thisishispersonalperspective.Ihavetreatedpatientswithheadandneckcancersformanyyears,soIhaveseen,upclose,thedifficultexperienceoflivingwithheadandneckcancer.Cancerisatryingsituationforallpatientsandtheirlovedones,butheadandneckpatientsfacecancerinauniqueanddifficultway,withtheirdiseaseandtumorsoftenvisibletothepublic.Ihavebeeninvolvedinresearchforyearsaspartofscientists'decades-longendeavortobringforwardmeaningfuladvancesforpatientsdiagnosedwiththispotentiallyaggressivedisease.Untilrecently,suchadvanceswerehardtocomebyandmypatientsandIstruggledwiththelimitedtreatmentoptionsavailable.Butwhilethereisasignificantneedfornewtreatmentoptions,thegoodnewsisthattherehavebeensomeimprovementsinsurvivalratesovertheyearsandweareseeinganewandencouragingfutureahead.Wehavebeguntoleverageourunderstandingofbiologytodevelopmoreprecisetherapies.AtMSD,wearefocusedonimmuno-oncologyresearch,whichstudiestheroleoftheimmunesystemindetectingandfightingcancer.Wearestudyingthepotentialofthisapproach,whichaimstoharnessandrestorethebodysabilitytodetectandfightcancercells,inanumberofcancers,includingheadandneckcancer.Immuno-oncologyhasalreadysignificantlychangedthewaycertaincancersaretreated,includingmelanomaandlungcancer,aswellasinthetreatmentofheadandneckcancer.Changeiscomingtotheheadandneckcancerlandscape–anditisthrillingtobeapartofit.TobeabletoseehowourresearchandeffortsatMSDarehavingadirectimpactonhowphysiciansapproachthetreatmentoftheirpatientsandwhatpatientsmayexpectfromtheirtreatmentiswhatmotivatesustoworkharder.Jameslikeslogicpuzzles.Andwordproblems.Luckily,hegetstoapplytheseinterestsinhisworkeveryday.Jamesisacomputationalchemist–heworkswithMSD’schemistryteams,applyingpredictivemodellingtoidentifywaystodesigndrugsandanalyzedatatohelpourscientistsprioritizethenextcompoundstomakeandtest.Althoughthesearecomplexproblemsandcomplexquestionsthatwe’retryingtosolve,wetakelogicalsteps,explainsJames.Foreveryquestion,there’sreallyananswer,yousometimesjusthavetospendalittlebitmoretimethinkingaboutit,andtakeastepbackandlookatwhat’sactuallyinfrontofyou.Bettermolecules,fasterInourgroup’sroleindrugdiscovery,wehavethismantraof‘bettermolecules,faster,saysJames.Ifachemisthas100compoundsthatshe’sthinkingaboutmaking,computationally,wecanhelpprioritizewhichonestostartwithbasedonrationaldrugdesign.Jamesenjoysbeingpartofateamworkingtoachieveasingulargoal:tocreatemedicinesthatwillhelpthepeoplewhoneedthem.And,hebelievesthatcollaborationisveryimportantforresearchanddevelopment:Youcan'tdoaprojectonyourown;youneedotherstoassistandhelp,notjustbycontributingintheirindividualrole,butalsowiththeirthinking.Jamesandhiscolleagueshavealotofexperiencewithperseveranceanddetermination,too.Ourteamsofscientistsdesign,developandscreenthousandsofcompoundsandantibodiestoultimatelyadvanceonlyafewofthemostpromisingleadcandidatesintoclinicaltesting.Moleculardesignanddevelopmentisaniterativeprocess.Youhavetostickwithit.It'scontinuouslymakingmodificationsandadaptingandevolving,eventuallygettingdowntheroadorthepipelinetomakeadrug…that'swhat'sexcitingaboutit.It’sallaboutthepatientsEveryday,IcometoworkknowingthatI’mworkingtomakeadrug.And,Idon'tknowiftodayI’mgoingtoopenupanemailwithresultssaying,‘we'veaccomplishedthisor‘weneedtochangethat.’Butregardlessofwhatthoseresultsare,it'sgoingtobeprogresstogettothatendpoint.”

  Ourcompanyiscommittedtodiscoveringsmart,sustainablewaystoexpandaccesstohealthcare,especiallyinareaswithlimitedinfrastructureandresources.Giventhesignificanceofthischallenge,itisonlybyworkinginpartnershipwithothers—governments,donors,patientorganizations,healthcareprofessionals,NGOs,academicinstitutions,multilateralorganizationsandtheprivatesector—thatwecanwemakethestrongestcontribution.TheMSDFellowshipforGlobalHealthisbuiltonthenotionofpartneringtostrengthenthecapacityandreachofnonprofitorganizationswhich,inturn,willultimatelysolvesomeoftheworld’sgreatesthealthcarechallenges.CarolineFox,M.D.ispassionateaboutgenetics.Inmedicalschool,shestudiedtheeffectsoftheenvironmentondiabetesandobesityonatribeofNativeAmericans(certainpopulationsworldwidehaveagreaterpropensitytowardsdiabetes;thistribewasonesuchgroup).Herresearchlefthermotivatedtolearnmoreabouthowgeneticsplaysaroleinmetabolicdiseases.Thatwasmystart,shenotes.Sincethen,almostallofmyresearchhasbeenfocusedonuncoveringthegeneticfoundationsofthesetypesofdiseases.ChangingPerceptionsPriortojoiningMSDResearchLaboratoriesinBoston,CarolineworkedattheNationalInstitutesofHealth.There,sheledalabthatstudiedmetabolicriskfactorsforcardiovasculardiseaseaspartofthe,apioneeringlong-termpopulationstudyofcardiovasculardisease.But,shenotes,theshifttoMSDwasarelativelyeasyone.IwasimpressedbyMSDseffortstoleveragehumangeneticstodrivedrugdiscovery,shesays.Forme,itwastheperfectnextstepfromtheworkthatIhadbeendoinginacademia.Genetics:TheNewFrontierWe'relucky—CarolinespassionforgeneticsisagreatfitforMSD.Inourlabsandacrosstheindustry,weareseeinganincreaseduseofhumangeneticstohelpdeterminewhetherpatientswillrespondtoacertaindrugornot,ShepointstoMSD'sactiveresearchcollaborationswithscientistsaroundtheworldaimedatadvancingthisfieldofscience.Iamveryenthusiasticaboutwhereourresearchmaylead.CarolineFox,M.D.ispassionateaboutgenetics.Inmedicalschool,shestudiedtheeffectsoftheenvironmentondiabetesandobesityonatribeofNativeAmericans(certainpopulationsworldwidehaveagreaterpropensitytowardsdiabetes;thistribewasonesuchgroup).Herresearchlefthermotivatedtolearnmoreabouthowgeneticsplaysaroleinmetabolicdiseases.Thatwasmystart,shenotes.Sincethen,almostallofmyresearchhasbeenfocusedonuncoveringthegeneticfoundationsofthesetypesofdiseases.ChangingPerceptionsPriortojoiningMSDResearchLaboratoriesinBoston,CarolineworkedattheNationalInstitutesofHealth.There,sheledalabthatstudiedmetabolicriskfactorsforcardiovasculardiseaseaspartofthe,apioneeringlong-termpopulationstudyofcardiovasculardisease.But,shenotes,theshifttoMSDwasarelativelyeasyone.IwasimpressedbyMSDseffortstoleveragehumangeneticstodrivedrugdiscovery,shesays.Forme,itwastheperfectnextstepfromtheworkthatIhadbeendoinginacademia.Genetics:TheNewFrontierWe'relucky—CarolinespassionforgeneticsisagreatfitforMSD.Inourlabsandacrosstheindustry,weareseeinganincreaseduseofhumangeneticstohelpdeterminewhetherpatientswillrespondtoacertaindrugornot,ShepointstoMSD'sactiveresearchcollaborationswithscientistsaroundtheworldaimedatadvancingthisfieldofscience.Iamveryenthusiasticaboutwhereourresearchmaylead.

  Toexpressourappreciation,MSDbegan#DearCancerHeroes–asocialmediacampaigntorecognizetheirfortitudeandcontributionstothefield.It’sasmallgesturetoshowourgratitude.Wewanttoletclinicaltrialparticipantsknowtheyarenotaloneandthereisawholecommunityofpeoplecheeringthemon.Anyonecanjointhemovementbywritingamessagetocancerclinicaltrialparticipantsonastickynoteandsharingitonsocialmediausing#DearCancerHeroes.Cancerresearchhascomealongwayandstillhasalongwaytogo.However,wewouldn’thavegottentowherewearetodaywithouttheseheroes.Chemistryhasbeencentraltoourbusinessofsinceourearliestdaysasacompany.Historically,ourdrugdiscoveryprocessprimarilycenteredaroundsmallmolecules.Then,thebirthofbiotechnologyinthelate1970s/early1980saddedbiologics,orengineeredproteins,tothemix.Today,newmodalitiesareemergingthatshowastrongpotentialtotargetcomplexdiseasesthathavenotyetbeenreachablewitheithersmallmoleculesorbiologics.RobGarbaccioisleadingatalentedteamofchemistswhoarehelpingguideMSD’sentryintothisexcitingnewfieldofmedicine.IntroducinganddiscoveringnewwaysforwardRobistheassociatevicepresident,ChemistryCapabilitiesforAcceleratingTherapeutics(CCAT),adiscoverychemistryteamthatislookingathowtogobeyondthetraditionalmethodsofdiscoveringanddevelopingmedicines."Therearecertaindiseasetargetsthatarereallyhardto'reach'andimpactusingtraditionalmethods,"henotes."SopartofthegroupIoverseetriestofigureouthowwecanemploynewermodalities,suchaspeptides,bioconjugates,andoligonucleotides,toaddressthechallengingtargetsthatareincreasinglyemergingfrombiologicalresearch."Rob'sgroupisnotfocusedonanyspecifictherapeuticarea--theyareseekingnewwaystoaddressthemostdifficultdiseasetargets."Inoncology,infectiousdiseases,andneuroscience,forexample,we’relookingforthosetargetsthatourcolleaguessay,'Ifonlywecouldmodulatethistarget,webelievewemightbeabletopotentiallyinterruptthediseaseprocessandhelppatients,'"henotes.Using‘creativechemistry’totreatdiseaseIt'scomplexwork,tobesure,butthat'swhatmakesitsointriguingandinspiringforRobandhisteam."ThethingthatIlikethemostaboutmyworkisthebeliefthattheremaybeapathforwardforthetreatmentofeachandeveryoneofthesediseases.Wejustcan'tseeityetbecausethebiologyissocomplex,"saysRob."Asresearcherscontinuetoimproveourunderstandingofdiseasebiology,Ibelievethatcombiningthatknowledgewithcreativechemistrywillhelpleadusdownnewroadstotreatingdiseaseandhelpingpatients."Robjoinedthecompanyaftercompletinggraduateschoolandapostdoctoralfellowshipfocusingonorganicchemistry."Icameherebecausescienceandinnovationdrivethiscompany.I'mpassionateaboutourmissiontosaveandimprovelives,andIbelievethatmybestdayatwork,thedaymyteammakesapotentiallylife-changingdiscovery,isstillaheadofme,andit'sthereasonthatIstay."InventingforlifeAtMSD,wesayweare.AndRobdefinitelyseeshimselfasaninventor."Chemistshavethisuniqueabilitytocombineatomsandbondsbetweenatomsinauniqueway.Everydaychemistsareinventinghundredsofmoleculesthathaveneverexistedbefore.So,yes,weareinventing,"hesays."Weareinventingtosolveproblems."Dr.Chenghasbeentreatingheadandneckcancerpatientsformanyyears.Thisishispersonalperspective.Ihavetreatedpatientswithheadandneckcancersformanyyears,soIhaveseen,upclose,thedifficultexperienceoflivingwithheadandneckcancer.Cancerisatryingsituationforallpatientsandtheirlovedones,butheadandneckpatientsfacecancerinauniqueanddifficultway,withtheirdiseaseandtumorsoftenvisibletothepublic.Ihavebeeninvolvedinresearchforyearsaspartofscientists'decades-longendeavortobringforwardmeaningfuladvancesforpatientsdiagnosedwiththispotentiallyaggressivedisease.Untilrecently,suchadvanceswerehardtocomebyandmypatientsandIstruggledwiththelimitedtreatmentoptionsavailable.Butwhilethereisasignificantneedfornewtreatmentoptions,thegoodnewsisthattherehavebeensomeimprovementsinsurvivalratesovertheyearsandweareseeinganewandencouragingfutureahead.Wehavebeguntoleverageourunderstandingofbiologytodevelopmoreprecisetherapies.AtMSD,wearefocusedonimmuno-oncologyresearch,whichstudiestheroleoftheimmunesystemindetectingandfightingcancer.Wearestudyingthepotentialofthisapproach,whichaimstoharnessandrestorethebodysabilitytodetectandfightcancercells,inanumberofcancers,includingheadandneckcancer.Immuno-oncologyhasalreadysignificantlychangedthewaycertaincancersaretreated,includingmelanomaandlungcancer,aswellasinthetreatmentofheadandneckcancer.Changeiscomingtotheheadandneckcancerlandscape–anditisthrillingtobeapartofit.TobeabletoseehowourresearchandeffortsatMSDarehavingadirectimpactonhowphysiciansapproachthetreatmentoftheirpatientsandwhatpatientsmayexpectfromtheirtreatmentiswhatmotivatesustoworkharder.

  Chemistryhasbeencentraltoourbusinessofsinceourearliestdaysasacompany.Historically,ourdrugdiscoveryprocessprimarilycenteredaroundsmallmolecules.Then,thebirthofbiotechnologyinthelate1970s/early1980saddedbiologics,orengineeredproteins,tothemix.Today,newmodalitiesareemergingthatshowastrongpotentialtotargetcomplexdiseasesthathavenotyetbeenreachablewitheithersmallmoleculesorbiologics.RobGarbaccioisleadingatalentedteamofchemistswhoarehelpingguideMSD’sentryintothisexcitingnewfieldofmedicine.IntroducinganddiscoveringnewwaysforwardRobistheassociatevicepresident,ChemistryCapabilitiesforAcceleratingTherapeutics(CCAT),adiscoverychemistryteamthatislookingathowtogobeyondthetraditionalmethodsofdiscoveringanddevelopingmedicines."Therearecertaindiseasetargetsthatarereallyhardto'reach'andimpactusingtraditionalmethods,"henotes."SopartofthegroupIoverseetriestofigureouthowwecanemploynewermodalities,suchaspeptides,bioconjugates,andoligonucleotides,toaddressthechallengingtargetsthatareincreasinglyemergingfrombiologicalresearch."Rob'sgroupisnotfocusedonanyspecifictherapeuticarea--theyareseekingnewwaystoaddressthemostdifficultdiseasetargets."Inoncology,infectiousdiseases,andneuroscience,forexample,we’relookingforthosetargetsthatourcolleaguessay,'Ifonlywecouldmodulatethistarget,webelievewemightbeabletopotentiallyinterruptthediseaseprocessandhelppatients,'"henotes.Using‘creativechemistry’totreatdiseaseIt'scomplexwork,tobesure,butthat'swhatmakesitsointriguingandinspiringforRobandhisteam."ThethingthatIlikethemostaboutmyworkisthebeliefthattheremaybeapathforwardforthetreatmentofeachandeveryoneofthesediseases.Wejustcan'tseeityetbecausethebiologyissocomplex,"saysRob."Asresearcherscontinuetoimproveourunderstandingofdiseasebiology,Ibelievethatcombiningthatknowledgewithcreativechemistrywillhelpleadusdownnewroadstotreatingdiseaseandhelpingpatients."Robjoinedthecompanyaftercompletinggraduateschoolandapostdoctoralfellowshipfocusingonorganicchemistry."Icameherebecausescienceandinnovationdrivethiscompany.I'mpassionateaboutourmissiontosaveandimprovelives,andIbelievethatmybestdayatwork,thedaymyteammakesapotentiallylife-changingdiscovery,isstillaheadofme,andit'sthereasonthatIstay."InventingforlifeAtMSD,wesayweare.AndRobdefinitelyseeshimselfasaninventor."Chemistshavethisuniqueabilitytocombineatomsandbondsbetweenatomsinauniqueway.Everydaychemistsareinventinghundredsofmoleculesthathaveneverexistedbefore.So,yes,weareinventing,"hesays."Weareinventingtosolveproblems."Ourcompanyiscommittedtodiscoveringsmart,sustainablewaystoexpandaccesstohealthcare,especiallyinareaswithlimitedinfrastructureandresources.Giventhesignificanceofthischallenge,itisonlybyworkinginpartnershipwithothers—governments,donors,patientorganizations,healthcareprofessionals,NGOs,academicinstitutions,multilateralorganizationsandtheprivatesector—thatwecanwemakethestrongestcontribution.TheMSDFellowshipforGlobalHealthisbuiltonthenotionofpartneringtostrengthenthecapacityandreachofnonprofitorganizationswhich,inturn,willultimatelysolvesomeoftheworld’sgreatesthealthcarechallenges.Dr.Chenghasbeentreatingheadandneckcancerpatientsformanyyears.Thisishispersonalperspective.Ihavetreatedpatientswithheadandneckcancersformanyyears,soIhaveseen,upclose,thedifficultexperienceoflivingwithheadandneckcancer.Cancerisatryingsituationforallpatientsandtheirlovedones,butheadandneckpatientsfacecancerinauniqueanddifficultway,withtheirdiseaseandtumorsoftenvisibletothepublic.Ihavebeeninvolvedinresearchforyearsaspartofscientists'decades-longendeavortobringforwardmeaningfuladvancesforpatientsdiagnosedwiththispotentiallyaggressivedisease.Untilrecently,suchadvanceswerehardtocomebyandmypatientsandIstruggledwiththelimitedtreatmentoptionsavailable.Butwhilethereisasignificantneedfornewtreatmentoptions,thegoodnewsisthattherehavebeensomeimprovementsinsurvivalratesovertheyearsandweareseeinganewandencouragingfutureahead.Wehavebeguntoleverageourunderstandingofbiologytodevelopmoreprecisetherapies.AtMSD,wearefocusedonimmuno-oncologyresearch,whichstudiestheroleoftheimmunesystemindetectingandfightingcancer.Wearestudyingthepotentialofthisapproach,whichaimstoharnessandrestorethebodysabilitytodetectandfightcancercells,inanumberofcancers,includingheadandneckcancer.Immuno-oncologyhasalreadysignificantlychangedthewaycertaincancersaretreated,includingmelanomaandlungcancer,aswellasinthetreatmentofheadandneckcancer.Changeiscomingtotheheadandneckcancerlandscape–anditisthrillingtobeapartofit.TobeabletoseehowourresearchandeffortsatMSDarehavingadirectimpactonhowphysiciansapproachthetreatmentoftheirpatientsandwhatpatientsmayexpectfromtheirtreatmentiswhatmotivatesustoworkharder.

  “MyuncleIvanwasaseverediabetespatient—heneededinjectionsthreetimesaday.Hewaswithoutinsulinformorethanamonth.EvenIwasnotaware,”Pablorecounts.“Whenhefinallyreceivedinsulin,hewasinbadcondition.Severalweekslater,hishealthdeclined,hehadrenalfailure,andhedied.”ThedroneteamrecentlyacknowledgedPablo’scontributions,andhispersonalloss,bygivingtheprojectanewnickname.Oncecalled“MajorTom”aftertheDavidBowiesong,it’snow“ProjectIvan.”“Idon’thavewordsenoughtoshowmygratitude,”Pablosays.“Thisisaboutsavinglives.”Toexpressourappreciation,MSDbegan#DearCancerHeroes–asocialmediacampaigntorecognizetheirfortitudeandcontributionstothefield.It’sasmallgesturetoshowourgratitude.Wewanttoletclinicaltrialparticipantsknowtheyarenotaloneandthereisawholecommunityofpeoplecheeringthemon.Anyonecanjointhemovementbywritingamessagetocancerclinicaltrialparticipantsonastickynoteandsharingitonsocialmediausing#DearCancerHeroes.Cancerresearchhascomealongwayandstillhasalongwaytogo.However,wewouldn’thavegottentowherewearetodaywithouttheseheroes.Historically,oncologypracticeandclinicaltrialdesignprimarilyfocusedonwherethetumorfirstemerged,suchascolonorrectum,lung,breast,andendometrium.Thisapproachfollowsthelogicofthescalpel:pinpointingthelocationofthetumorfirstenabledsurgicalplans.Morerecently,therehavebeensignificantadvancesinourunderstandingoftheroleofcancerbiomarkersinmolecularandcellularmechanismsthatcandrivetumorgrowth.Biomarkersarebiologicalmolecules(typicallycomprisedofDNA,RNAorprotein)foundintissuesorbloodthatcanserveasasigntobetterunderstandaconditionordisease.Sometimes,thesamebiomarkerisfoundacrossmanydifferenttypesofcancer,regardlessofwherethetumorfirstdeveloped.Withinaspecifictumorlocation,thesebiomarkerscansometimesdifferentiatewhetherthetumorislikelytorespondtoagiventreatment.Assuch,thesebiomarkershavebeenusedtohelpinformclinicalresearch,acceleratingtheprocessofgettingtargetedmedicinestopatientswhereseparatetrialswouldtakeyearstoconduct.Importantly,insomecases,thesefeaturescanbeassessedusinglaboratoryteststhathavelongbeenavailable.Whereatestiseithernotavailable,orforresearchuseonly,thetestmanufacturerpartnerswiththedrugmanufacturertoadvancetogetherintoregulatoryapprovalbygovernmentagencies(suchastheFDA)acompaniondiagnosticassaytoensuresafeandeffectiveuseofthedruginpatientslikelytorespond.Thegoalistouseadeeperunderstandingofthetumorbiologyandassociatedbiomarkerstotackletumorresearchmoreprecisely;goingbeyondsimplywhereatumorarose.Instead,wearelearninghowtoattackacancerbasedonitsbiologyatthecellularlevel.AtMSD,effortsareunderwaytobetterunderstandmicrosatelliteinstability(MSI)andmismatchrepairdeficiency(dMMR).Thesebiomarkersarepresentacrosstumortypes,regardlessoftheoriginallocationofthecancer.ThepresenceofhighlevelsofMSI(MSI-H)ordMMRsignifiesanunderlyingprobleminacell'sabilitytofixerrorsthatoccurwhenDNAreplicates.TumorcellsdeterminedtohaveMSI-HordMMRharborhundredstothousandsofmutations.Theultimateproofofoureffortswillmanifestasanewgenerationofcancermedicines:thosethatfollowthelogicofbiology,notthelogicofthescalpel.

  CarolineFox,M.D.ispassionateaboutgenetics.Inmedicalschool,shestudiedtheeffectsoftheenvironmentondiabetesandobesityonatribeofNativeAmericans(certainpopulationsworldwidehaveagreaterpropensitytowardsdiabetes;thistribewasonesuchgroup).Herresearchlefthermotivatedtolearnmoreabouthowgeneticsplaysaroleinmetabolicdiseases.Thatwasmystart,shenotes.Sincethen,almostallofmyresearchhasbeenfocusedonuncoveringthegeneticfoundationsofthesetypesofdiseases.ChangingPerceptionsPriortojoiningMSDResearchLaboratoriesinBoston,CarolineworkedattheNationalInstitutesofHealth.There,sheledalabthatstudiedmetabolicriskfactorsforcardiovasculardiseaseaspartofthe,apioneeringlong-termpopulationstudyofcardiovasculardisease.But,shenotes,theshifttoMSDwasarelativelyeasyone.IwasimpressedbyMSDseffortstoleveragehumangeneticstodrivedrugdiscovery,shesays.Forme,itwastheperfectnextstepfromtheworkthatIhadbeendoinginacademia.Genetics:TheNewFrontierWe'relucky—CarolinespassionforgeneticsisagreatfitforMSD.Inourlabsandacrosstheindustry,weareseeinganincreaseduseofhumangeneticstohelpdeterminewhetherpatientswillrespondtoacertaindrugornot,ShepointstoMSD'sactiveresearchcollaborationswithscientistsaroundtheworldaimedatadvancingthisfieldofscience.Iamveryenthusiasticaboutwhereourresearchmaylead.“MyuncleIvanwasaseverediabetespatient—heneededinjectionsthreetimesaday.Hewaswithoutinsulinformorethanamonth.EvenIwasnotaware,”Pablorecounts.“Whenhefinallyreceivedinsulin,hewasinbadcondition.Severalweekslater,hishealthdeclined,hehadrenalfailure,andhedied.”ThedroneteamrecentlyacknowledgedPablo’scontributions,andhispersonalloss,bygivingtheprojectanewnickname.Oncecalled“MajorTom”aftertheDavidBowiesong,it’snow“ProjectIvan.”“Idon’thavewordsenoughtoshowmygratitude,”Pablosays.“Thisisaboutsavinglives.”In1962hercollaborators,JamesWatson,FrancisCrickandMauriceWilkinswereawardedtheNobelPrizefortheir“discoveriesconcerningthemolecularstructureofnucleicacidsanditssignificanceforinformationtransferinlivingmaterial.”Franklin’suntimelydeathdeniedhertheacclaimofthisprestigiousscientificaward(theNobelCommitteedoesnotawardtheprizeposthumously),butherroleinthisfundamentaldiscoveryhasbeenwelldocumentedandisnowwidelyrecognized.Franklin’sstoryofalifecutshortbyovariancancerremainsalltoocommon.Eventoday,advancedovariancancerremainsoneofthemostdifficultcancerstotreat.Butthereremainsareasonforoptimism.Thepaceofchangeincancertreatmenthasincreaseddramaticallyinrecentyears.Advancesinresearch–manyofwhichmaybetracedbacktoFranklin’swork–havegivenusadeeperunderstandingofhowtotargetthedisease,pavingthewayfornewdevelopments.Specifictoovariancancer,recentclinicalresearchhasshownpromiseforwomenwithadvancedstagesofthedisease.AtMSD,wearefocusedontranslatingbreakthroughscienceintooncologytherapeuticsthathavethegreatestpotentialforimprovinglong-termdiseasecontrolandsurvivalforpatients,includingthosewithovariancancer.Werecognizethatnotwopatientsorcancersarethesameandmultipleapproaches–therapeuticregimensandmechanismsofaction–willbeneededtooutpacethisdisease.That’swhywehaveworkedrigorouslytoexpandanddiversifyourowninternalresearchprograms.Thereisstillworktobedone,butwebelievestronglyinourpotentialtotransformthewayallcancersaretreated.AndweareconstantlyinspiredtoworkharderbystorieslikeRosalindFranklin’s.

  Historically,oncologypracticeandclinicaltrialdesignprimarilyfocusedonwherethetumorfirstemerged,suchascolonorrectum,lung,breast,andendometrium.Thisapproachfollowsthelogicofthescalpel:pinpointingthelocationofthetumorfirstenabledsurgicalplans.Morerecently,therehavebeensignificantadvancesinourunderstandingoftheroleofcancerbiomarkersinmolecularandcellularmechanismsthatcandrivetumorgrowth.Biomarkersarebiologicalmolecules(typicallycomprisedofDNA,RNAorprotein)foundintissuesorbloodthatcanserveasasigntobetterunderstandaconditionordisease.Sometimes,thesamebiomarkerisfoundacrossmanydifferenttypesofcancer,regardlessofwherethetumorfirstdeveloped.Withinaspecifictumorlocation,thesebiomarkerscansometimesdifferentiatewhetherthetumorislikelytorespondtoagiventreatment.Assuch,thesebiomarkershavebeenusedtohelpinformclinicalresearch,acceleratingtheprocessofgettingtargetedmedicinestopatientswhereseparatetrialswouldtakeyearstoconduct.Importantly,insomecases,thesefeaturescanbeassessedusinglaboratoryteststhathavelongbeenavailable.Whereatestiseithernotavailable,orforresearchuseonly,thetestmanufacturerpartnerswiththedrugmanufacturertoadvancetogetherintoregulatoryapprovalbygovernmentagencies(suchastheFDA)acompaniondiagnosticassaytoensuresafeandeffectiveuseofthedruginpatientslikelytorespond.Thegoalistouseadeeperunderstandingofthetumorbiologyandassociatedbiomarkerstotackletumorresearchmoreprecisely;goingbeyondsimplywhereatumorarose.Instead,wearelearninghowtoattackacancerbasedonitsbiologyatthecellularlevel.AtMSD,effortsareunderwaytobetterunderstandmicrosatelliteinstability(MSI)andmismatchrepairdeficiency(dMMR).Thesebiomarkersarepresentacrosstumortypes,regardlessoftheoriginallocationofthecancer.ThepresenceofhighlevelsofMSI(MSI-H)ordMMRsignifiesanunderlyingprobleminacell'sabilitytofixerrorsthatoccurwhenDNAreplicates.TumorcellsdeterminedtohaveMSI-HordMMRharborhundredstothousandsofmutations.Theultimateproofofoureffortswillmanifestasanewgenerationofcancermedicines:thosethatfollowthelogicofbiology,notthelogicofthescalpel.Chemistryhasbeencentraltoourbusinessofsinceourearliestdaysasacompany.Historically,ourdrugdiscoveryprocessprimarilycenteredaroundsmallmolecules.Then,thebirthofbiotechnologyinthelate1970s/early1980saddedbiologics,orengineeredproteins,tothemix.Today,newmodalitiesareemergingthatshowastrongpotentialtotargetcomplexdiseasesthathavenotyetbeenreachablewitheithersmallmoleculesorbiologics.RobGarbaccioisleadingatalentedteamofchemistswhoarehelpingguideMSD’sentryintothisexcitingnewfieldofmedicine.IntroducinganddiscoveringnewwaysforwardRobistheassociatevicepresident,ChemistryCapabilitiesforAcceleratingTherapeutics(CCAT),adiscoverychemistryteamthatislookingathowtogobeyondthetraditionalmethodsofdiscoveringanddevelopingmedicines."Therearecertaindiseasetargetsthatarereallyhardto'reach'andimpactusingtraditionalmethods,"henotes."SopartofthegroupIoverseetriestofigureouthowwecanemploynewermodalities,suchaspeptides,bioconjugates,andoligonucleotides,toaddressthechallengingtargetsthatareincreasinglyemergingfrombiologicalresearch."Rob'sgroupisnotfocusedonanyspecifictherapeuticarea--theyareseekingnewwaystoaddressthemostdifficultdiseasetargets."Inoncology,infectiousdiseases,andneuroscience,forexample,we’relookingforthosetargetsthatourcolleaguessay,'Ifonlywecouldmodulatethistarget,webelievewemightbeabletopotentiallyinterruptthediseaseprocessandhelppatients,'"henotes.Using‘creativechemistry’totreatdiseaseIt'scomplexwork,tobesure,butthat'swhatmakesitsointriguingandinspiringforRobandhisteam."ThethingthatIlikethemostaboutmyworkisthebeliefthattheremaybeapathforwardforthetreatmentofeachandeveryoneofthesediseases.Wejustcan'tseeityetbecausethebiologyissocomplex,"saysRob."Asresearcherscontinuetoimproveourunderstandingofdiseasebiology,Ibelievethatcombiningthatknowledgewithcreativechemistrywillhelpleadusdownnewroadstotreatingdiseaseandhelpingpatients."Robjoinedthecompanyaftercompletinggraduateschoolandapostdoctoralfellowshipfocusingonorganicchemistry."Icameherebecausescienceandinnovationdrivethiscompany.I'mpassionateaboutourmissiontosaveandimprovelives,andIbelievethatmybestdayatwork,thedaymyteammakesapotentiallylife-changingdiscovery,isstillaheadofme,andit'sthereasonthatIstay."InventingforlifeAtMSD,wesayweare.AndRobdefinitelyseeshimselfasaninventor."Chemistshavethisuniqueabilitytocombineatomsandbondsbetweenatomsinauniqueway.Everydaychemistsareinventinghundredsofmoleculesthathaveneverexistedbefore.So,yes,weareinventing,"hesays."Weareinventingtosolveproblems."Toexpressourappreciation,MSDbegan#DearCancerHeroes–asocialmediacampaigntorecognizetheirfortitudeandcontributionstothefield.It’sasmallgesturetoshowourgratitude.Wewanttoletclinicaltrialparticipantsknowtheyarenotaloneandthereisawholecommunityofpeoplecheeringthemon.Anyonecanjointhemovementbywritingamessagetocancerclinicaltrialparticipantsonastickynoteandsharingitonsocialmediausing#DearCancerHeroes.Cancerresearchhascomealongwayandstillhasalongwaytogo.However,wewouldn’thavegottentowherewearetodaywithouttheseheroes.

  Dr.Chenghasbeentreatingheadandneckcancerpatientsformanyyears.Thisishispersonalperspective.Ihavetreatedpatientswithheadandneckcancersformanyyears,soIhaveseen,upclose,thedifficultexperienceoflivingwithheadandneckcancer.Cancerisatryingsituationforallpatientsandtheirlovedones,butheadandneckpatientsfacecancerinauniqueanddifficultway,withtheirdiseaseandtumorsoftenvisibletothepublic.Ihavebeeninvolvedinresearchforyearsaspartofscientists'decades-longendeavortobringforwardmeaningfuladvancesforpatientsdiagnosedwiththispotentiallyaggressivedisease.Untilrecently,suchadvanceswerehardtocomebyandmypatientsandIstruggledwiththelimitedtreatmentoptionsavailable.Butwhilethereisasignificantneedfornewtreatmentoptions,thegoodnewsisthattherehavebeensomeimprovementsinsurvivalratesovertheyearsandweareseeinganewandencouragingfutureahead.Wehavebeguntoleverageourunderstandingofbiologytodevelopmoreprecisetherapies.AtMSD,wearefocusedonimmuno-oncologyresearch,whichstudiestheroleoftheimmunesystemindetectingandfightingcancer.Wearestudyingthepotentialofthisapproach,whichaimstoharnessandrestorethebodysabilitytodetectandfightcancercells,inanumberofcancers,includingheadandneckcancer.Immuno-oncologyhasalreadysignificantlychangedthewaycertaincancersaretreated,includingmelanomaandlungcancer,aswellasinthetreatmentofheadandneckcancer.Changeiscomingtotheheadandneckcancerlandscape–anditisthrillingtobeapartofit.TobeabletoseehowourresearchandeffortsatMSDarehavingadirectimpactonhowphysiciansapproachthetreatmentoftheirpatientsandwhatpatientsmayexpectfromtheirtreatmentiswhatmotivatesustoworkharder.In1962hercollaborators,JamesWatson,FrancisCrickandMauriceWilkinswereawardedtheNobelPrizefortheir“discoveriesconcerningthemolecularstructureofnucleicacidsanditssignificanceforinformationtransferinlivingmaterial.”Franklin’suntimelydeathdeniedhertheacclaimofthisprestigiousscientificaward(theNobelCommitteedoesnotawardtheprizeposthumously),butherroleinthisfundamentaldiscoveryhasbeenwelldocumentedandisnowwidelyrecognized.Franklin’sstoryofalifecutshortbyovariancancerremainsalltoocommon.Eventoday,advancedovariancancerremainsoneofthemostdifficultcancerstotreat.Butthereremainsareasonforoptimism.Thepaceofchangeincancertreatmenthasincreaseddramaticallyinrecentyears.Advancesinresearch–manyofwhichmaybetracedbacktoFranklin’swork–havegivenusadeeperunderstandingofhowtotargetthedisease,pavingthewayfornewdevelopments.Specifictoovariancancer,recentclinicalresearchhasshownpromiseforwomenwithadvancedstagesofthedisease.AtMSD,wearefocusedontranslatingbreakthroughscienceintooncologytherapeuticsthathavethegreatestpotentialforimprovinglong-termdiseasecontrolandsurvivalforpatients,includingthosewithovariancancer.Werecognizethatnotwopatientsorcancersarethesameandmultipleapproaches–therapeuticregimensandmechanismsofaction–willbeneededtooutpacethisdisease.That’swhywehaveworkedrigorouslytoexpandanddiversifyourowninternalresearchprograms.Thereisstillworktobedone,butwebelievestronglyinourpotentialtotransformthewayallcancersaretreated.AndweareconstantlyinspiredtoworkharderbystorieslikeRosalindFranklin’s.In1962hercollaborators,JamesWatson,FrancisCrickandMauriceWilkinswereawardedtheNobelPrizefortheir“discoveriesconcerningthemolecularstructureofnucleicacidsanditssignificanceforinformationtransferinlivingmaterial.”Franklin’suntimelydeathdeniedhertheacclaimofthisprestigiousscientificaward(theNobelCommitteedoesnotawardtheprizeposthumously),butherroleinthisfundamentaldiscoveryhasbeenwelldocumentedandisnowwidelyrecognized.Franklin’sstoryofalifecutshortbyovariancancerremainsalltoocommon.Eventoday,advancedovariancancerremainsoneofthemostdifficultcancerstotreat.Butthereremainsareasonforoptimism.Thepaceofchangeincancertreatmenthasincreaseddramaticallyinrecentyears.Advancesinresearch–manyofwhichmaybetracedbacktoFranklin’swork–havegivenusadeeperunderstandingofhowtotargetthedisease,pavingthewayfornewdevelopments.Specifictoovariancancer,recentclinicalresearchhasshownpromiseforwomenwithadvancedstagesofthedisease.AtMSD,wearefocusedontranslatingbreakthroughscienceintooncologytherapeuticsthathavethegreatestpotentialforimprovinglong-termdiseasecontrolandsurvivalforpatients,includingthosewithovariancancer.Werecognizethatnotwopatientsorcancersarethesameandmultipleapproaches–therapeuticregimensandmechanismsofaction–willbeneededtooutpacethisdisease.That’swhywehaveworkedrigorouslytoexpandanddiversifyourowninternalresearchprograms.Thereisstillworktobedone,butwebelievestronglyinourpotentialtotransformthewayallcancersaretreated.AndweareconstantlyinspiredtoworkharderbystorieslikeRosalindFranklin’s.

  In1962hercollaborators,JamesWatson,FrancisCrickandMauriceWilkinswereawardedtheNobelPrizefortheir“discoveriesconcerningthemolecularstructureofnucleicacidsanditssignificanceforinformationtransferinlivingmaterial.”Franklin’suntimelydeathdeniedhertheacclaimofthisprestigiousscientificaward(theNobelCommitteedoesnotawardtheprizeposthumously),butherroleinthisfundamentaldiscoveryhasbeenwelldocumentedandisnowwidelyrecognized.Franklin’sstoryofalifecutshortbyovariancancerremainsalltoocommon.Eventoday,advancedovariancancerremainsoneofthemostdifficultcancerstotreat.Butthereremainsareasonforoptimism.Thepaceofchangeincancertreatmenthasincreaseddramaticallyinrecentyears.Advancesinresearch–manyofwhichmaybetracedbacktoFranklin’swork–havegivenusadeeperunderstandingofhowtotargetthedisease,pavingthewayfornewdevelopments.Specifictoovariancancer,recentclinicalresearchhasshownpromiseforwomenwithadvancedstagesofthedisease.AtMSD,wearefocusedontranslatingbreakthroughscienceintooncologytherapeuticsthathavethegreatestpotentialforimprovinglong-termdiseasecontrolandsurvivalforpatients,includingthosewithovariancancer.Werecognizethatnotwopatientsorcancersarethesameandmultipleapproaches–therapeuticregimensandmechanismsofaction–willbeneededtooutpacethisdisease.That’swhywehaveworkedrigorouslytoexpandanddiversifyourowninternalresearchprograms.Thereisstillworktobedone,butwebelievestronglyinourpotentialtotransformthewayallcancersaretreated.AndweareconstantlyinspiredtoworkharderbystorieslikeRosalindFranklin’s.CarolineFox,M.D.ispassionateaboutgenetics.Inmedicalschool,shestudiedtheeffectsoftheenvironmentondiabetesandobesityonatribeofNativeAmericans(certainpopulationsworldwidehaveagreaterpropensitytowardsdiabetes;thistribewasonesuchgroup).Herresearchlefthermotivatedtolearnmoreabouthowgeneticsplaysaroleinmetabolicdiseases.Thatwasmystart,shenotes.Sincethen,almostallofmyresearchhasbeenfocusedonuncoveringthegeneticfoundationsofthesetypesofdiseases.ChangingPerceptionsPriortojoiningMSDResearchLaboratoriesinBoston,CarolineworkedattheNationalInstitutesofHealth.There,sheledalabthatstudiedmetabolicriskfactorsforcardiovasculardiseaseaspartofthe,apioneeringlong-termpopulationstudyofcardiovasculardisease.But,shenotes,theshifttoMSDwasarelativelyeasyone.IwasimpressedbyMSDseffortstoleveragehumangeneticstodrivedrugdiscovery,shesays.Forme,itwastheperfectnextstepfromtheworkthatIhadbeendoinginacademia.Genetics:TheNewFrontierWe'relucky—CarolinespassionforgeneticsisagreatfitforMSD.Inourlabsandacrosstheindustry,weareseeinganincreaseduseofhumangeneticstohelpdeterminewhetherpatientswillrespondtoacertaindrugornot,ShepointstoMSD'sactiveresearchcollaborationswithscientistsaroundtheworldaimedatadvancingthisfieldofscience.Iamveryenthusiasticaboutwhereourresearchmaylead.In1962hercollaborators,JamesWatson,FrancisCrickandMauriceWilkinswereawardedtheNobelPrizefortheir“discoveriesconcerningthemolecularstructureofnucleicacidsanditssignificanceforinformationtransferinlivingmaterial.”Franklin’suntimelydeathdeniedhertheacclaimofthisprestigiousscientificaward(theNobelCommitteedoesnotawardtheprizeposthumously),butherroleinthisfundamentaldiscoveryhasbeenwelldocumentedandisnowwidelyrecognized.Franklin’sstoryofalifecutshortbyovariancancerremainsalltoocommon.Eventoday,advancedovariancancerremainsoneofthemostdifficultcancerstotreat.Butthereremainsareasonforoptimism.Thepaceofchangeincancertreatmenthasincreaseddramaticallyinrecentyears.Advancesinresearch–manyofwhichmaybetracedbacktoFranklin’swork–havegivenusadeeperunderstandingofhowtotargetthedisease,pavingthewayfornewdevelopments.Specifictoovariancancer,recentclinicalresearchhasshownpromiseforwomenwithadvancedstagesofthedisease.AtMSD,wearefocusedontranslatingbreakthroughscienceintooncologytherapeuticsthathavethegreatestpotentialforimprovinglong-termdiseasecontrolandsurvivalforpatients,includingthosewithovariancancer.Werecognizethatnotwopatientsorcancersarethesameandmultipleapproaches–therapeuticregimensandmechanismsofaction–willbeneededtooutpacethisdisease.That’swhywehaveworkedrigorouslytoexpandanddiversifyourowninternalresearchprograms.Thereisstillworktobedone,butwebelievestronglyinourpotentialtotransformthewayallcancersaretreated.AndweareconstantlyinspiredtoworkharderbystorieslikeRosalindFranklin’s.

责任编辑:www.00gvb.com_www.00gvb.com-【APP官网】社友网:未经授权不得转载
关键词 >>

继续阅读

热新闻

热话题

热门推荐

关于我们 联系我们 版权声明 网站地图
百站百胜: “曹园”大门夜间有吊车施工一夜施工已拆除牌匾 美媒:忘记硅谷吧,中国这座城市将炙手可热 汇丰研究:华润置地目标价升至40.6元维持买入评级 量子计算机永远无法成功?可这场马拉松开跑才十分钟 腾讯京东裁减管理层,中层只有两条路可走 第一太平2018年净利增9%至1.32亿美元末期息5… 标普银行股指数19个成员无一幸免连续4天全面下跌 美银美林:华晨中国目标价降至8.3元维持中性评级 派生科技实控人控制2家公司:1家\"找不到\"1家已… 巴西没内马尔变二流?瞧这青春风暴美洲杯真有戏 花旗:金山软件目标价升至21元维持买入评级 NGT48山口真帆事件公布调查结果:成员与此事无关 直击盐城爆炸事故救援深夜献血的民众仍排着长队 楼市初春:想买房得拼手速?投资客看到了机会 男性口服避孕药预计10年后上市 美国2月预算赤字创单月历史新高 日棒球之神铃木一朗退休人生最后的打席被游击捕捉 故宫院内考古发现:南薰殿现明清排水沟 花旗:中国重汽目标价升至8元维持沽售评级 上汽大众途岳将新增入门车型搭载1.2T发动机 中腾信收缩线下团队小花钱包力撑线上分期 特斯拉新董事长:在我看来马斯克发推特很明智 《欲望都市》将拍续作讲述50岁女人的爱与友谊 联讯策略:首批科创板名单公布关注三条投资主线 2019中国发展高层论坛嘉宾观点汇总 大摩:申洲国际目标价降至110元维持增持评级 中教控股拟发行23.55亿可换股债券 英镑兑美元跌逾1%跌破1.31并抹去一周涨幅 孙杨800自创新高尚有不足奥运争冠本钱还不够 建业地产2018年度多赚42.26%派息14.12港… 风口故事变事故?电子烟遭曝光新零售成棋子 专业坑妻这个男人狂怼特朗普殊不知妻子心里苦 德国商报:德银和德国商业银行的员工共同反对合并 原AKB筱田麻里子婚后首次出席活动自曝想当妈妈 醫美產業夯萬能科大成立醫學美容教學研究中心 《都挺好》家庭,爱和被爱与面对和成长 美银美林:长实集团目标价升至77元维持买入评级 白敬亭要鞋不要女友?井柏然斩钉截铁被本尊打脸 亿万富翁Forrest警告:全球铁矿石市场可能供不应求 陸委會擬修韓國瑜條款鄭文燦:規範應清楚可依循 懒人在床上就可以减肥的6个动作 中国花滑双人滑回顾:从申雪赵宏博到隋文静韩聪 收益率曲线倒挂,美股衰退征兆显现? 特朗普通俄门落幕两党甩锅进入“新一轮战斗” 三人报销二哥23中6仍横扫火箭!联盟第一太强了 三场1球未进!人和进攻顽疾仍在二年级魔咒难摆脱 新债王质疑美联储政策立场突转坚持美股仍处熊市 美银美林:华晨中国目标价降至8.3元维持中性评级 央视:国奥暴露诸多问题还是靠高空轰炸解决战斗 精子游动的秘密:尾部具有强化层做出强有力摆动 从宁泽涛到张国伟中国运动员“商业”路该怎么走 麦莉打扮“穿越”引回忆重现10年前青涩造型 美媒:忘记硅谷吧,中国这座城市将炙手可热 HMD澄清:诺基亚7Plus数据泄露系人为失误,已经… 美国名校招生丑闻:支付650万美元的家长身份仍是谜 两天暴跌1.92万亿3000点再度失守A股反弹结束了… 网约车第一股Lyft上市首日开涨21%市值达253亿… 《都挺好》家庭伦理大PK!测测你的价值观 NBA众星为开拓者大将祝福这本是他巅峰一季 国际奥委会批准日本奥委会主席竹田辞去委员职务 载通2018年纯利跌16.49%至7.20亿港元末期… 江苏盐城爆炸地曾因爆炸谣言引上万人连夜逃命 悲观预警经济增长美联储又和白宫唱反调 钱江晚报:婚恋网站套路深急于求成易被坑 网友爆料蔚来交付汽车是“自导自演”官方尚未回应 攻克阿尔兹海默症的曙光:成人脑中发现新生神经元 13中12在场净胜30分!季后赛没来死神先来了 21分17篮板5助攻3盖帽!被黑最惨的男人爆发了 特朗普和美国政客频收死亡威胁他们做错了什么? 耀莱集团3月25日回购500万股耗资164万港币 钯金盘中突然跳水急跌近11美元 范丞丞自曝心酸日常:每天只睡两三个小时 泰国主帅揭露崛起秘诀:靠足球环境基层教练要够多 高露承认吴非也不是省油的灯,论心机远远超过林小娘 权威机构警告:下一场危机,新兴市场和欧洲将被重创 响水爆炸中的幼儿园有100余孩子卷帘门都被震坏 逆势而行试驾领克02高能版车型 论坛发帖、互动平台追问竟这样造出10倍超级概念股 实探高鑫零售旗下大润发卖场:新零售改造涨成本 波音737Max停飞料对一些美国经济数据产生影响 大麻市场仍然被低估,Cronos的强劲增长才刚刚开始 蔚来汽车早盘大涨4%此前称国家补贴下降后不会涨价 机器人有办公室?美媒刊文:全球化或威胁白领岗位 3万亿美元外卖市场暗战互联网便利性颠覆传统模式 美债收益率曲线倒挂几天就恐慌?持续一个季度再研判 卡纳瓦罗遇“开门黑”中国男足0比1不敌泰国无缘中国… 佐藤健举办30周岁纪念演出再次挑战落语 欧盟对耐克公司罚款1,250万欧元因其限制跨地区销售 华电国际现下跌4%去年多赚2.3倍兼加派息 俄战机一天内在波罗的海上空两次伴飞美轰炸机 雷克萨斯LM疑似售价曝光4月16日首发 谁的板蓝花?62件商标归属成谜正大旗下企业陷纠纷 量子纠缠,我们能够用它干什么呢? iPhoneSE2真的要来了A12芯片+3DTou… 性感女教练身材火辣男学员爆满 美债收益率倒挂不止联储官员相继表态:降息?想多了 “女性买房猛增”揭露:成年人的安全感,只能自己给 台媒谈韩国瑜访问澳门:“卖菜郎”变身“卖花郎” 法国总统爱丽舍宫设宴知情人确认巩俐受邀出席 管理资金超300亿的谢治宇:年初的上涨只是导火索 A股史上第六次牛市正在酝酿股改后最强牛市袭来? 陕西一县交警大队长酒后驾车被当街带走已被免职 软银参与中国人工智能创企达闼科技3亿美元融资轮 二手车电商\"达摩克利斯之剑\"高悬:裁员、保证金难退 阿根廷还是熟悉的烂!西媒:梅西一直在被拖累 ofo内部发反腐文件要追回损失解决资金困境 导航,遇见十年:第十届中国卫星导航年会五月北京召开 北方矿业去年亏损4.8亿元不派息 工信部拟撤销部分新能源车免购置税资格涉北汽、比亚迪、… 1+1>2?AmazonPay联手Worldpay未… 小小周身高直逼昆凌腰部网友:走路姿势像周杰伦 中国国航涨近2%去年多赚1%惟减派息 春遊竹縣最好康最高補助兩千五百元 Kudlow希望美联储“立即”降息50个基点 正—反物质不对称性有了新证据 芯片产业成科创板首批受理大赢家:九家公司占据三席 孙杨心疼萩野公介:好好活着比什么都重要 胜利郑俊英换手机警方考虑调查是否预谋销毁罪证 美军欲将杜鲁门号航母提前25年退役遭议员质问 美军方高官渲染“中国军事威胁论”国防部:坚决反对 继拿下《华尔街日报》后苹果新闻又签约Vox Lyft上市了,它的司机们却罢工了 中国自动化去年度亏损大幅收窄不派息 波音737Max被禁飞美国航空公司每天取消90个航班 梅尔·B自曝与队友发生关系辣妹重组巡演或泡汤 李彦宏:中国改变技术 如何投资5G:买入这2只基金10只股票就够了 暗访河北邢台违建别墅群项目曾上报建设酒店客房 联盟第一再遭重创!高塔伤停1月分区决赛复出? 宝马董事长:在北京买单想刷卡朋友直接刷手机 空客获中国创纪录订单300架飞机订单价值近300亿欧 仅此一辆法拉利P80/C官图发布 罗林泉:应通过媒体增进亚洲人民相互了解 响水爆炸:男子在500米外看到明火后被冲击波击倒 51信用卡去年转赚近22亿人民币不派末期息 直击|咪蒙公司解散给员工颁发毕业证称“公司垮了” 支持川普建墙五角大楼批款10亿美元 U23亚洲杯正赛名单:国奥再出战争三张奥运门票 多款App点分享至微信会跳深圳航空App?微信:被劫持 比亚迪发布王朝全新A+级SUV 北京消协:网购、在线旅游网约车大数据杀熟问题最多 美国将全面改革航空安全监管规则 北京支持雄安三所新建学校今年开工 三个月过去,你的ofo退押金排号前进了多少? 每天不想做事只想躺着?NASA有份工作很适合你 菲亚特500将在明年转向电动化 韩红发文为林俊杰庆生:愿你一切安好如愿 “神药”风波一年后广告再被停播莎普爱思剑走偏锋 疑似科尔维特C8配置表曝光搭8速双离合 2021赛艇世锦赛会徽亮相以东方明珠为主体 全球经济放缓催生美联储降息预期 高盛:中海油目标价升至15.65元维持买入评级 倪光南殷承良韩旭共话5G:为自动驾驶带来啥改变 从技术角度去分析AT&T会不会迎来重大突破? “火烧赤壁”准备一年有余航拍镜头耗18万资金 两名公安部A级通缉令嫌疑人自首涉盗掘古墓葬犯罪 10亿赌局:雷军输给董明珠小米赢了格力 何小鹏:新能源车补贴退坡是利好,赴美上市系误解 于谦分享爱\"烫头\"原因这次牺牲爱好将头发拉直了 美债曲线倒挂的前世今生:倒挂和衰退会再次重演吗? 华泰联合证券董事长刘晓丹:科创板带来了什么? 瑞银:申洲国际目标价升至117元维持买入评级 亚美能源去年盈利4亿人民币股息7.37分 梅罗时代的绝活不比老马们少他们都有一手.gif 长江证券:美欧股债缘何暴动警惕新兴经济体尾部风险 郑敏强任浙江金华市委常委组织部长 国泰航空飙近3%斥逾49亿收购香港快运 第10次连任亲民党主席宋楚瑜对参选2020表态 意大利留学生谈“一带一路”:会带来更好工作机会 丹东港489亿债务危机“诈尸”谎言:资产注水疑云密布 小鹏汽车:新能源车补贴退坡是利好赴美上市系误解 艺点意创巩书凯:保持对当前现状不满 鼎好大厦易主:折射中关村电子大卖场16年兴衰 昆汀新片预告公开惊现布拉德·彼特对打李小龙 瑞·达利欧:经济和市场原理与我们所处的位置 大西雅圖地區賞花地圖,櫻花、鬱金香、山茶、水仙去這些地… FF与九城正式签署协议第三次\"联姻\"能否解燃眉之… 事关待遇和晋升中央发文推公务员职务与职级并行 媒体:特朗普甩“通俄”包袱落下伤民主党还有牌 挑战自我!蔡卓妍抛开偶像包袱力争影后 美警告欧盟尽快启动贸易磋商谁当总统立场都不会变 2018中国运动员传播影响力榜发布武大靖排名首位 两代孙悟空相见!六小龄童林更新罕见同框合影 港铁今年可加价3.3%首次启动“封顶机制” 浓眉哥缺阵兰德尔34分鹈鹕苦战断绝国王希望 柳鑫宇要演“渣男”王诗玥:是爱恨情没有仇 英媒:特雷莎梅须作辞职表态换取议会批准其脱欧协议 美国1月对华贸易逆差收窄对华出口跌至八年新低 索尼宣布将关闭北京工厂智能手机生产转移至泰国 湖南客车起火已致26死交通部派工作组赶赴现场 胡彦斌以董事长身份入学湖畔大学关联企业共18家 苹果变\"软\"了这届网友的态度却很“硬”! 意大利返还796件中国文物外国网友的回复亮了 味千中国经营溢利降23%曾因投资百度外卖巨亏近5亿 浅田真央披露索契冬奥会幕后故事曾跟姐姐争吵 生产指导引人不安,投资者要小心特斯拉的哪些举动? 瑞信:通达集团目标价上调至1.1元维持跑赢大市评级